Hypothyroidism and >3 levothyroxin purchases

HYPOTHY_PURCHASE

hypothyroidism: Abnormally low levels of thyroid hormone.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions HYPOTHYROIDISM	68551
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints HYPOTHY_LEVOTHY	67640
6. Filter based on genotype QC (FinnGen only)	65350

Control definitions (FinnGen only)

Control exclude: E4_MALNUTRITION, E4_DIABETES, I9_CVD, C3_CANCER, MENINGITIS, ENCEPHALITIS, HYPOTHYROIDISM, D3_ANAEMIA, F5_ALLANXIOUS, F5_MOOD, F5_SCHIZO, F5_BEHEMOCHILD, F5_UNSMENDIS, ANOSMIA, ANTIDEPRESSANTS
Control conditions: not HYPOTHYROIDISM

Extra metadata

First used in FinnGen datafreeze: DF3

NAME	HYPOTHY_PURCHASE
CONTROL_EXCLUDE	E4_MALNUTRITION\|E4_DIABETES\|I9_CVD\|C3_CANCER\|MENINGITIS\|ENCEPHALITIS\|HYPOTHYROIDISM\|D3_ANAEMIA\|F5_ALLANXIOUS\|F5_MOOD\|F5_SCHIZO\|F5_BEHEMOCHILD\|F5_UNSMENDIS\|ANOSMIA\|ANTIDEPRESSANTS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!HYPOTHYROIDISM
SEX
INCLUDE	HYPOTHY_LEVOTHY
PRE_CONDITIONS
CONDITIONS	HYPOTHYROIDISM
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hypothyroidism and >3 levothyroxin purchases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	65350	52289	13061
Unadjusted period prevalence (%)	16.04	18.55	5.98
Median age at first event (years)	52.99	51.19	60.19

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
17542: Matched controls
99162

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

48.7

322.4

305

A28

ICPC

Limited function/disability NOS

4.5

321.9

995

1295

A04

ICPC

Weakness/tiredness general

2.7

321.3

2247

5120

J01DB01

ATC

cefalexin; oral

2.1

320.7

13884

63793

L03AA13

ATC

pegfilgrastim; parenteral

52.3

320.3

300

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

106.8

320.0

279

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

319.7

6423

22834

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

5.9

319.1

754

753

Z71.8

ICD-10 Finland

Other specified counselling

2.0

316.5

5073

16638

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

23.2

316.2

350

I47.1

ICD-10 Finland

Supraventricular tachycardia

22.5

314.3

351

F31

ICD-10 Finland

Bipolar affective disorder

153.2

312.8

267

N02AJ06

ATC

codeine and paracetamol; systemic

1.9

311.8

6290

22345

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

6.7

311.1

657

576

I20.99

ICD-10 Finland

Angina pectoris, unspecified

87.7

310.6

275

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.2

310.0

3750

11019

N02BF02

ATC

pregabalin; oral

5.8

309.8

734

735

F99

ICD-10 Finland

Mental disorder, not otherwise specified

35.0

309.4

310

M04AA01

ATC

allopurinol; systemic

5.1

309.0

834

956

R42

ICD-10 Finland

Dizziness and giddiness

2.5

307.7

2515

6199

E10

ICD-10 Finland

Type 1 diabetes mellitus

801.7

307.7

413

B01AA03

ATC

warfarin; systemic

30.7

307.7

936

182

TPH04

NOMESCO Finland

Cathetrisation of vein

2.8

307.7

2557

5626

SPAT1240

SPAT

Therapeutic discussion

4.3

307.7

2218

3261

JN4AD

NOMESCO Finland

Body CT examination

8.0

307.7

707

518

C07AB02

ATC

metoprolol; systemic

5.7

307.7

1541

1660

SPAT1249

SPAT

Treatment-related counselling outside office

2.1

307.7

6540

22218

N03AX09

ATC

lamotrigine; oral

21.6

307.7

1142

318

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

462.3

307.7

1075

N05AH04

ATC

quetiapine; oral

15.8

307.7

3573

1584

103

Kela drug reimbursment

Diabetes, insulin-treated

6888.5

307.7

3047

N05CF02

ATC

zolpidem; oral

3.6

307.7

2492

4310

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

8.1

307.7

1003

741

A04AA02

ATC

granisetron; systemic, transdermal

76.9

307.7

425

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

174.1

307.7

421

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

12.9

307.7

495

222

N03AG01

ATC

valproic acid; systemic, rectal

10.9

307.7

1049

576

R5140

NOMESCO Finland

Monitoring the use of the aid

3.8

307.7

1347

2140

A10BJ02

ATC

liraglutide; parenteral

72.0

307.7

325

ZY010

NOMESCO Finland

Hospital outpatient

12.4

307.7

1008

484

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

56.4

307.7

352

205

Kela drug reimbursment

Chronic hypertension

+∞

307.7

1563

H04AA01

ATC

glucagon; nasal, parenteral

594.0

307.7

609

N05AN01

ATC

lithium; oral

203.7

307.7

592

WX408

NOMESCO Finland

General anesthesy, balanced

2.6

307.7

3442

8659

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

16.2

307.7

442

158

207

Kela drug reimbursment

Chronic arrhythmias

333.0

307.7

625

N06AX12

ATC

bupropion; oral

33.0

307.7

1759

334

R07.4

ICD-10 Finland

Chest pain, unspecified

3.0

307.7

3072

6586

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

9.7

307.7

523

312

H02AB02

ATC

dexamethasone; systemic

16.3

307.7

890

325

ZXE10

NOMESCO Finland

More than one and less than three hours

2.5

307.7

4525

12170

P74

ICPC

Anxiety disorder/anxiety state

8.0

307.7

810

600

F41.1

ICD-10 Finland

Generalized anxiety disorder

10.7

307.7

1080

604

E03.89

ICD-10 Finland

Other specified hypothyroidism

309.0

307.7

1988

PHD99

NOMESCO Finland

Resection of other vein

2392.4

307.7

419

N06AB03

ATC

fluoxetine; oral

20.8

307.7

1890

573

IGY99

NOMESCO Finland

Other psychiatric treatment contact

47.9

307.7

406

P06

ICPC

Sleep disturbance

3.3

307.7

1930

3613

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

10.1

307.7

2162

1366

E66.00

ICD-10 Finland

Metabolic syndrome

8.8

307.7

747

498

E66.8

ICD-10 Finland

Other obesity

7.4

307.7

1102

894

A10AE04

ATC

insulin glargine; parenteral

121.7

307.7

1297

A10AB05

ATC

insulin aspart; parenteral

182.0

307.7

1228

N06AB04

ATC

citalopram; systemic

18.8

307.7

3223

1173

F61.0

ICD-10 Finland

Mixed personality disorders

134.2

307.7

349

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

564.7

307.7

580

N06AB05

ATC

paroxetine; oral

22.7

307.7

926

243

I48

ICD-10 Finland

Atrial fibrillation and flutter

96.5

307.7

907

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

72.1

307.7

301

N05BA01

ATC

diazepam; systemic, rectal

5.7

307.7

1645

1775

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

16.3

307.7

1228

455

N06AX22

ATC

agomelatine; oral

72.1

307.7

460

R03AC02

ATC

salbutamol; inhalant

2.1

307.7

9164

34173

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

548.0

307.7

472

P99

ICPC

Psychological disorders other

15.1

307.7

561

216

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

84.2

307.7

878

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

29.5

307.7

611

121

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

78.0

307.7

444

ZXE20

NOMESCO Finland

More than three and less than five hours

4.0

307.7

1326

1978

A02BC02

ATC

pantoprazole; systemic

2.8

307.7

9992

31894

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

5.5

307.7

1131

1229

A10BK01

ATC

dapagliflozin; oral

236.1

307.7

605

F29

ICD-10 Finland

Unspecified nonorganic psychosis

489.1

307.7

586

N06AX21

ATC

duloxetine; oral

19.4

307.7

1992

652

C08CA01

ATC

amlodipine; oral

3.8

307.7

3174

5442

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

307.7

685

N06AX16

ATC

venlafaxine; oral

52.0

307.7

2945

383

F40.1

ICD-10 Finland

Social phobias

16.1

307.7

477

172

C10AA07

ATC

rosuvastatin; oral

2.6

307.7

3386

8233

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

129.2

307.7

786

F34.1

ICD-10 Finland

Dysthymia

53.9

307.7

697

UJF32

NOMESCO Finland

Coloscopy

2.9

307.7

2714

5878

F33

ICD-10 Finland

Recurrent depressive disorder

35.1

307.7

448

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

6.8

307.7

698

597

P01

ICPC

Feeling anxious/nervous/tense

3.3

307.7

2728

5178

N05CD07

ATC

temazepam; oral

10.3

307.7

908

523

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

9.5

307.7

584

359

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

120.3

307.7

695

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

8.4

307.7

681

475

C03CA01

ATC

furosemide; systemic

12.8

307.7

1980

974

D64.9

ICD-10 Finland

Anaemia, unspecified

10.1

307.7

735

427

F32

ICD-10 Finland

Depressive episode

11.8

307.7

997

503

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

21.3

307.7

1056

297

P29

ICPC

Psychological sympt/compl other

4.5

307.7

1395

1881

N06AA09

ATC

amitriptyline; systemic

7.7

307.7

941

721

N03AE01

ATC

clonazepam; systemic

7.9

307.7

688

507

BAA60

NOMESCO Finland

Total thyroidectomy

359.7

307.7

1405

N05BA12

ATC

alprazolam; oral

7.9

307.7

1217

922

XF402

NOMESCO Finland

ECG with work load test

7.0

307.7

773

647

N06AA12

ATC

doxepin; systemic

16.4

307.7

442

156

OAB50, ,

SPAT

10.0

307.7

630

368

E03

ICD-10 Finland

Other hypothyroidism

295.9

307.7

3684

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

14.5

307.7

468

187

M79.6

ICD-10 Finland

Pain in limb

2.1

307.7

6182

20599

C10AX09

ATC

ezetimibe; oral

5.9

307.7

1365

1391

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

506.3

307.7

933

Z2446

NOMESCO Finland

Social worker

7.2

307.7

897

739

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

101.0

307.7

333

A10AE05

ATC

insulin detemir; parenteral

648.7

307.7

873

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

8.0

307.7

783

576

C10AA01

ATC

simvastatin; oral

3.6

307.7

3051

5478

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

4.9

307.7

997

1201

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

6.7

307.7

2203

2076

N06AX05

ATC

trazodone; oral

58.2

307.7

393

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

51.1

307.7

645

A10BA02

ATC

metformin; oral

28.5

307.7

3091

738

C10AA05

ATC

atorvastatin; oral

3.4

307.7

3768

7296

C09AA02

ATC

enalapril; systemic

4.4

307.7

1369

1868

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

97.0

307.7

287

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

75.0

307.7

300

A10BH01

ATC

sitagliptin; oral

543.1

307.7

737

ZYC01

NOMESCO Finland

Remote contact by phone

5.7

307.7

862

885

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

47.4

307.7

505

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.0

307.7

1243

1854

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

10.5

307.7

1414

822

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.7

307.7

2374

5379

XF400

NOMESCO Finland

ECG with 12 standard connections

4.4

307.7

1368

1871

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

8.3

307.7

2090

1598

I25.1

ICD-10 Finland

Atherosclerotic heart disease

98.4

307.7

1110

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2410.1

307.7

422

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

7.9

307.7

623

458

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

97.7

307.7

1488

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

65.4

307.7

374

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

7.9

307.7

982

742

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.4

307.7

3593

9564

C01DA14

ATC

isosorbide mononitrate; oral

39.6

307.7

570

A06AD11

ATC

lactulose; oral

4.5

307.7

1193

1587

A10AC01

ATC

insulin (human); parenteral

23.1

307.7

1143

298

T82

ICPC

Obesity

6.8

307.7

816

707

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

74.6

307.7

324

F41.09

ICD-10 Finland

UNS Panic Syndrome

14.8

307.7

485

190

EP1AE

NOMESCO Finland

Neck ultrasound examination

8.0

307.7

1166

871

XCK10

NOMESCO Finland

Photography of fundus of eye

5.4

307.7

887

971

I50.9

ICD-10 Finland

Heart failure, unspecified

160.3

307.7

496

AN1

Coronary angiography

118.4

307.7

548

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

12.3

307.7

659

313

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

564

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

307.7

556

Z2445

NOMESCO Finland

Psychologist

11.7

307.7

723

363

N05CF01

ATC

zopiclone; oral

4.7

307.7

4052

5999

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

37.4

307.7

662

104

Kela drug reimbursment

Thyroid insufficiency

7847.4

307.7

3388

R51.80

ICD-10 Finland

Headache

2.6

307.7

2699

6565

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

165.7

307.7

401

R06.0

ICD-10 Finland

Dyspnoea

3.3

307.7

3248

6360

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

+∞

307.7

694

T89

ICPC

Diabetes insulin dependent

312.4

307.7

842

F90.0

ICD-10 Finland

Disturbance of activity and attention

7.3

307.7

747

597

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

307.7

643

N06BA04

ATC

methylphenidate; oral

7.7

307.7

675

512

C07AA05

ATC

propranolol; systemic

4.4

307.7

3866

5990

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

533.1

307.7

8253

165

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

17.7

307.7

414

135

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

307.7

6037

19238

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

71.6

307.7

311

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

3.9

307.7

1451

2240

R53

ICD-10 Finland

Malaise and fatigue

3.0

307.7

3996

8850

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

6.0

307.7

1014

1005

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

8.8

307.7

1418

984

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

80.5

307.7

308

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

307.7

570

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

7.0

307.7

766

643

A10BK03

ATC

empagliflozin; oral

529.3

307.7

889

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

141.0

307.7

1273

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

11.5

307.7

910

471

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

307.7

430

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

596.0

307.7

611

G47.3

ICD-10 Finland

Sleep apnoea

3.6

307.7

3423

6253

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.5

307.7

1550

2687

Z3231

NOMESCO Finland

Registered nurse

2.9

307.7

3532

8041

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

80.9

307.7

541

C09AA05

ATC

ramipril; oral

5.7

307.7

1714

1862

E11

ICD-10 Finland

Type 2 diabetes mellitus

26.4

307.7

1320

305

N05AA02

ATC

levomepromazine; systemic

86.9

307.7

609

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

10.3

307.7

654

373

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

5.8

307.7

2093

2248

C08CA13

ATC

lercanidipine; oral

4.8

307.7

1002

1243

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

135.3

307.7

466

WZC00

NOMESCO Finland

Treatment plan or consultation

2.2

307.7

5475

17247

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

75.8

307.7

508

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

+∞

307.7

1274

N05BA06

ATC

lorazepam; systemic, sublingual

28.1

307.7

558

116

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

3.5

307.7

1956

3464

A03FA01

ATC

metoclopramide; systemic, rectal

3.9

307.7

2676

4388

AA1AD

NOMESCO Finland

CT of head and brain

3.9

307.7

2665

4316

N05AB03

ATC

perphenazine; systemic, rectal

70.4

307.7

449

N05BA04

ATC

oxazepam; oral

7.2

307.7

4097

4030

H03BB01

ATC

carbimazole; oral

15.9

307.7

1500

578

N06AB10

ATC

escitalopram; oral

15.6

307.7

4124

1912

A06AC01

ATC

ispaghula (psylla seeds); oral

2.8

307.7

3123

7221

E66.01

ICD-10 Finland

Obesity due to excess calories

5.3

307.7

1927

2260

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

9.4

307.7

594

369

N05AX12

ATC

aripiprazole; systemic

324.9

307.7

977

N02AX02

ATC

tramadol; systemic, rectal

2.5

307.7

5446

15096

B01AB05

ATC

enoxaparin; parenteral

2.9

307.7

3407

7672

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

107.0

307.7

407

N02AA05

ATC

oxycodone; systemic

6.1

307.7

1335

1328

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

+∞

307.7

1472

A10AB04

ATC

insulin lispro; parenteral

152.1

307.7

623

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

16.2

307.7

880

323

H02AB09

ATC

hydrocortisone; systemic

14.8

307.7

619

245

A02BC05

ATC

esomeprazole; systemic

2.2

307.7

5572

17468

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

116.0

307.7

518

SPAT1262

SPAT

Handing over of treatment supplies

9.3

307.7

2115

1439

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.9

307.7

3882

6771

N06AB06

ATC

sertraline; oral

26.6

307.7

2190

529

N05AX08

ATC

risperidone; systemic

27.8

307.7

1071

231

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

354.7

307.7

1649

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

572.6

307.7

682

N03AX16

ATC

[U] pregabalin

4.0

307.7

2982

4844

B03BA03

ATC

hydroxocobalamin; parenteral

10.1

307.7

513

294

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

16.0

307.7

700

257

215

Kela drug reimbursment

Diabetes, non-insulin-treated

16384.0

307.7

2995

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

+∞

307.7

394

F32.1

ICD-10 Finland

Moderate depressive episode

10.8

307.7

1175

654

N06AX03

ATC

mianserin; oral

30.9

307.7

515

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

89.8

307.7

434

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

655.7

307.7

986

A10AA01, ,

ATC

2886.5

307.7

502

I10

ICD-10 Finland

Essential (primary) hypertension

3.4

307.7

5681

12142

XF404

NOMESCO Finland

Ambulatory ECG

9.1

307.7

649

416

F32.9

ICD-10 Finland

Depressive episode, unspecified

20.6

307.7

2720

875

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.3

307.7

1702

3150

H03AA01

ATC

levothyroxine sodium; systemic

+∞

307.7

17542

728

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

6.9

307.7

714

608

IGY02

NOMESCO Finland

Psychiatric monitoring contact

36.8

307.7

518

B01AC04

ATC

clopidogrel; oral

16.2

307.7

840

307

C07AB07

ATC

bisoprolol; oral

6.7

307.7

5060

5682

115

Kela drug reimbursment

Breast cancer

+∞

307.7

479

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

7.2

307.7

772

630

PJA12

NOMESCO Finland

Sentinel node biopsy

21.0

307.7

457

126

T86

ICPC

Hypothyroidism/myxoedema

200.4

307.7

2337

P03

ICPC

Feeling depressed

5.4

307.7

2076

2392

Z01.8

ICD-10 Finland

Other specified special examinations

2.6

307.7

3248

7966

N02BE01

ATC

paracetamol; systemic, rectal

2.8

307.7

14546

62713

WX402

NOMESCO Finland

General anaesthesia

2.6

307.7

3074

7451

F31.8

ICD-10 Finland

Other bipolar affective disorders

183.1

307.7

442

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.2

307.7

1850

3560

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

60.1

307.7

2135

228

T90

ICPC

Diabetes non-insulin dependent

32.5

307.7

2336

467

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

78.6

307.7

434

A10AE06

ATC

insulin degludec; parenteral

+∞

307.7

589

P76

ICPC

Depressive disorder

16.1

307.7

1358

515

N06CA01

ATC

amitriptyline and psycholeptics; systemic

4.8

307.7

1118

1384

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

8.8

307.7

1377

950

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

11.3

307.7

770

402

A10AB01

ATC

insulin (human); parenteral

453.3

307.7

694

N03AX12

ATC

[U] gabapentin; oral

3.9

307.7

2043

3260

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

7.3

307.7

2541

2258

JN4BD

NOMESCO Finland

Extensive body CT

8.0

307.7

752

551

N06AX11

ATC

mirtazapine; oral

6.6

307.7

5426

6270

XX3DW

NOMESCO Finland

Time consuming IT work

6.4

307.7

920

852

F51.0

ICD-10 Finland

Nonorganic insomnia

3.0

307.7

2791

5896

N06AG02

ATC

moclobemide; oral

29.9

307.7

444

A10AA02, ,

ATC

2928.4

307.7

509

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

33.9

307.7

1862

346

T36

ICD-10 Finland

Poisoning by systemic antibiotics

22.5

307.7

792

208

A11CC03

ATC

alfacalcidol; systemic

43.6

307.7

348

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

100.3

307.7

416

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.8

307.7

5514

10638

C03DA01

ATC

spironolactone; oral

7.3

307.7

929

756

N06AX26

ATC

vortioxetine; oral

42.0

307.7

1478

217

N05AH03

ATC

olanzapine; systemic

154.8

307.7

1152

N05AF03

ATC

chlorprothixene; systemic

267.5

307.7

417

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.6

307.7

3532

6452

TPH07

NOMESCO Finland

Cathetrisation of artery

6.5

307.7

915

836

WZC30

NOMESCO Finland

Teaching

4.0

307.7

1850

2819

N05BE01

ATC

buspirone; oral

42.1

307.7

415

H02AB06

ATC

prednisolone; systemic

2.1

307.7

6711

22331

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

6.0

307.7

782

763

B01AF02

ATC

apixaban; oral

21.3

307.7

566

155

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.6

307.7

2627

6335

A10BJ06

ATC

semaglutide; parenteral

+∞

307.7

590

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.9

306.6

1161

1785

A02BC01

ATC

omeprazole; systemic

2.2

304.8

3358

9483

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

5.9

304.0

714

708

E66.9

ICD-10 Finland

Obesity, unspecified

6.4

303.6

659

597

SPAT1097

SPAT

Recording of ECG

3.5

303.4

1328

2270

C03AA03

ATC

hydrochlorothiazide; oral

8.6

302.9

528

357

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

21.4

301.8

342

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

95.0

301.3

265

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

63.2

300.7

275

SPAT1310

SPAT

Counselling related to known health issue

2.0

300.3

4710

15274

C09CA06

ATC

candesartan; oral

2.4

300.1

2853

7546

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.8

299.9

1152

1790

S18

ICPC

Laceration/cut

1.9

299.7

5600

19322

WF002

NOMESCO Finland

Radical radiotherapy

21.6

299.2

338

C09CA01

ATC

losartan; oral

2.6

298.3

2152

4974

SPAT1263

SPAT

Sampling

1.9

296.5

6545

23858

L28

ICPC

Limited function/disability (L)

3.2

293.5

1460

2718

WX110

NOMESCO Finland

Infiltration anesthesia

1.9

292.8

12152

53951

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

1068.5

292.1

359

R4110

NOMESCO Finland

Physiotherapy

2.3

291.9

2960

8050

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

2020.5

291.8

356

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

+∞

291.8

353

M79.7

ICD-10 Finland

Fibromyalgia

8.3

291.3

520

364

F43.1

ICD-10 Finland

Post-traumatic stress disorder

7.9

291.3

536

392

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.7

291.1

1178

1902

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

4.9

290.7

823

987

ZX120

NOMESCO Finland

Intravenous

4.3

290.2

958

1318

TFP20

NOMESCO Finland

Cardiodefibrillation

520.5

289.9

361

F41.00

ICD-10 Finland

Moderate panic disorder

65.6

288.8

263

J01AA02

ATC

doxycycline; systemic

1.9

288.1

11576

50719

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.0

287.5

4365

13952

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

+∞

286.9

347

A04AA55

ATC

palonosetron, combinations; systemic

58.0

284.7

263

A04AA01

ATC

ondansetron; systemic, rectal

5.1

284.5

769

882

J45.9

ICD-10 Finland

Asthma, unspecified

2.4

282.7

2451

6198

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

52.2

281.8

264

E06.3

ICD-10 Finland

Autoimmune thyroiditis

22.9

280.2

311

R02

ICPC

Shortness of breath/dyspnoea

3.1

279.7

1514

2969

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.9

279.4

793

953

WX872

NOMESCO Finland

Intensive care

14.5

279.3

366

146

M54.5

ICD-10 Finland

Low back pain

1.9

279.0

5545

19436

SPAT1260

SPAT

Consultation of another employee

2.4

277.6

2392

6027

SPAT1301

SPAT

No procedures

2.0

276.5

4274

13721

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

78.7

276.3

247

A02BC03

ATC

lansoprazole; oral

2.2

276.0

3148

8981

G44.2

ICD-10 Finland

Tension-type headache

2.5

272.9

2206

5387

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

+∞

271.9

329

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

11.8

271.9

393

193

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

19.0

271.5

320

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

30.8

271.2

279

ZXD10

NOMESCO Finland

Scheduled procedure

2.0

270.7

4623

15359

ZXE00

NOMESCO Finland

One hour or less

1.9

270.3

5425

19036

WX892

NOMESCO Finland

Monitored bed care

5.8

268.2

640

645

F39

ICD-10 Finland

Unspecified mood [affective] disorder

22.1

267.4

300

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

1844.4

267.0

326

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.1

266.9

1392

2665

N07BB01

ATC

disulfiram; oral

7.4

266.5

518

408

L17

ICPC

Foot/toe symptom/complaint

2.1

265.5

3686

11348

N06AB08

ATC

fluvoxamine; oral

30.1

264.0

273

Z3226

NOMESCO Finland

Physiotherapist

2.6

264.0

2032

4838

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

263.9

2515

6628

C08CA02

ATC

felodipine; oral

7.4

263.6

511

401

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

262.6

6713

25373

E66

ICD-10 Finland

Obesity

4.0

260.5

923

1344

P01AB01

ATC

metronidazole; oral, rectal

1.8

260.3

5812

21050

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

38.5

259.3

255

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

257.9

4159

13507

F60.9

ICD-10 Finland

Personality disorder, unspecified

54.8

256.8

239

K78

ICPC

Atrial fibrillation/flutter

44.1

256.0

246

R50.9

ICD-10 Finland

Fever, unspecified

2.5

254.9

2023

4886

101

Kela drug reimbursment

Anterior pituitary hypofunction

20.3

254.3

293

C02AC05

ATC

moxonidine; oral

22.6

250.2

279

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

4.5

249.6

774

1007

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

1721.5

249.6

305

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

249.4

4550

15390

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

13.3

249.2

339

147

N05AH02

ATC

clozapine; systemic

592.3

248.8

309

L03

ICPC

Low back symptom/complaint

1.9

248.6

4131

13532

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

301.5

248.5

315

I49.3

ICD-10 Finland

Ventricular premature depolarization

5.8

248.4

588

587

M03BX02

ATC

tizanidine; oral

1.7

247.5

9968

42742

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1704.0

247.1

302

E23.00

ICD-10 Finland

Panhypopituitarism

103.0

247.0

216

ZY000

NOMESCO Finland

Hospital inpatient

89.1

246.5

218

J02AC01

ATC

fluconazole; systemic

1.8

246.1

6388

24131

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.4

245.3

2236

5762

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

244.9

5005

17554

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

9.8

243.3

389

229

N05AD01

ATC

haloperidol; systemic

22.8

242.9

270

N02BF01

ATC

gabapentin; oral

3.8

242.7

945

1479

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

93.7

241.9

213

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

7.1

241.7

485

398

L03AA02

ATC

filgrastim; parenteral

69.3

240.8

218

R11

ICD-10 Finland

Nausea and vomiting

3.2

239.7

1179

2171

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

12.4

238.7

335

155

SPAT1234

SPAT

Support of social functional capacity

8.4

238.7

422

291

JN3AD

NOMESCO Finland

Abdominal CT examination

3.2

238.5

1157

2111

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.7

237.2

1607

3572

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

+∞

236.2

286

R4190

NOMESCO Finland

Nutritional therapy

6.4

236.2

516

470

A10BH05

ATC

linagliptin; oral

1610.6

233.9

286

177

Kela drug reimbursment

Insulin glargine 300 U / ml

1610.6

233.9

286

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.4

233.8

1070

1878

Z51.5

ICD-10 Finland

Palliative care

14.9

233.0

301

116

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

35.9

232.9

232

SPAT1243

SPAT

Psychiatric/psychological examination

6.3

231.6

511

471

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

5.1

231.0

621

707

N04AA02

ATC

biperiden; systemic

39.2

230.6

226

PHD76

NOMESCO Finland

Resection of long saphenous vein

823.3

230.1

284

WF003

NOMESCO Finland

Adjuvant radiotherapy

51.3

228.9

215

XA800

NOMESCO Finland

Neuropsychological investigation

5.9

224.9

528

522

SPAT1153

SPAT

Removal of sutures

2.0

224.7

3497

11142

A10BB12

ATC

glimepiride; oral

533.8

224.1

279

HA1AA

NOMESCO Finland

X-ray mammography

5.3

223.7

576

628

SPAT1307

SPAT

Psychosocial counselling and guidance

2.9

223.5

1301

2653

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

+∞

223.0

270

F32.8

ICD-10 Finland

Other depressive episodes

19.0

222.6

262

201

Kela drug reimbursment

Chronic cardiac insufficiency

42.4

222.4

215

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

4.0

222.1

797

1170

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

4.4

221.3

707

943

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

24.9

220.5

239

N06AA06

ATC

trimipramine; systemic

17.9

220.4

265

L02BA01

ATC

tamoxifen; oral

23.8

219.6

241

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.0

219.2

1192

2334

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

317.6

219.0

277

M25.5

ICD-10 Finland

Pain in joint

1.8

218.9

4848

17322

J01MA12

ATC

levofloxacin; systemic

2.5

218.9

1790

4370

A10BD07

ATC

metformin and sitagliptin; systemic

772.2

216.9

268

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

19.5

216.1

252

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

107.4

215.6

188

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

6.0

214.9

497

483

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1470.8

214.0

262

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

83.1

212.4

189

Z2221

NOMESCO Finland

Medical doctor

1.9

212.3

3542

11534

J01FF01

ATC

clindamycin; systemic

1.9

212.1

3563

11629

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.7

211.9

9031

38623

C07AG02

ATC

carvedilol; oral

12.1

211.6

301

143

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

211.4

256

M03BC01

ATC

orphenadrine (citrate); systemic

1.9

210.9

3477

11273

SPAT1252

SPAT

Overall medication plan or its review

5.3

210.7

541

588

H3600, E103,

ICD-10 Finland

+∞

209.7

254

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

11.7

209.0

302

148

ZXA10

NOMESCO Finland

Bilateral

2.3

208.5

1955

5080

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

208.3

2398

6800

HAC20

NOMESCO Finland

Total mastectomy

42.6

208.0

201

B81

ICPC

Anaemia vit B12/folate deficiency

10.8

207.1

313

167

R60.0

ICD-10 Finland

Localized oedema

3.1

205.4

1086

2088

Angiography of the heart and coronary arteries

60.0

205.4

189

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

70.5

204.7

185

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.7

202.9

793

1242

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

202.8

3001

9354

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

42.9

202.1

195

I20.09

ICD-10 Finland

Unstable angina

245.9

201.8

258

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

201.8

5037

18564

R00.2

ICD-10 Finland

Palpitations

3.0

200.0

1102

2172

A02BA02

ATC

ranitidine; systemic

2.4

199.9

1708

4249

N04BC05

ATC

pramipexole; oral

3.9

199.7

726

1076

SPAT1229

SPAT

Assessment of need for aid

4.7

198.8

577

706

ZXD05

NOMESCO Finland

Urgent procedure

1.8

198.7

4165

14559

R06AE07

ATC

cetirizine; oral

1.7

198.2

7178

29247

SPAT1216

SPAT

Assessment of functional ability

2.8

197.7

1251

2670

WX002

NOMESCO Finland

Sedation and analgesia

2.3

197.6

1844

4776

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.5

197.3

1602

3889

ZXE30

NOMESCO Finland

More than five and less than seven hours

6.4

197.0

425

381

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

60.8

197.0

181

M79.0

ICD-10 Finland

Rheumatism, unspecified

7.6

196.8

371

280

M54.4

ICD-10 Finland

Lumbago with sciatica

2.1

196.3

2423

7051

M03BC51

ATC

orphenadrine, combinations; systemic

1.8

195.6

3891

13372

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

11.4

195.2

286

144

F20.9

ICD-10 Finland

Schizophrenia, unspecified

1325.6

193.3

237

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

+∞

193.2

234

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

+∞

193.2

234

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

192.8

4329

15428

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

192.3

1799

4661

M01AE03

ATC

ketoprofen; systemic, rectal

1.8

191.4

4317

15402

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

14.3

190.4

250

100

J01MA02

ATC

ciprofloxacin; systemic

1.8

190.0

4471

16145

A01

ICPC

Pain general/multiple sites

3.1

188.4

989

1891

TPX10

NOMESCO Finland

Implantation of vascular injection port

13.5

188.3

254

108

E0000UV, ,

ATC

1.7

188.3

6373

25419

C09BA02

ATC

enalapril and diuretics; systemic

6.7

188.1

391

335

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

31.3

187.4

192

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

23.2

187.3

207

J01FA06

ATC

roxithromycin; oral

1.7

187.0

5319

20246

P72

ICPC

Schizophrenia

270.9

186.2

237

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

269.8

185.4

236

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

184.8

8534

36741

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

14.1

184.7

244

SPAT1312

SPAT

General health counselling

1.7

184.5

5117

19330

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

19.5

184.4

215

K59.09

ICD-10 Finland

Constipation, unspecified

4.3

184.0

593

796

TK800

NOMESCO Finland

Hemodialysis

37.1

183.9

182

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

10.3

183.5

284

158

I25.2

ICD-10 Finland

Old myocardial infarction

+∞

182.4

221

TFP34

NOMESCO Finland

Electrophysiological investigation

265.1

182.1

232

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.8

180.9

1156

2477

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.8

180.6

1150

2460

OAB93, ,

SPAT

2.8

180.1

1089

2263

H36.00

ICD-10 Finland

Diabetic background retinopathy

429.0

179.6

225

M01AE02

ATC

naproxen; oral, rectal

1.6

179.6

9150

40230

F41.8

ICD-10 Finland

Other specified anxiety disorders

4.7

178.9

529

658

C61

ICD-10 Finland

Malignant neoplasm of prostate

10.5

178.6

274

150

C01AA05

ATC

digoxin; systemic

25.5

178.4

192

F33.8

ICD-10 Finland

Other recurrent depressive disorders

70.6

178.2

161

R01AD09

ATC

mometasone; nasal

1.6

178.1

7532

31637

L01BC06

ATC

capecitabine; oral

89.5

177.6

157

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

+∞

177.4

215

SPAT1254

SPAT

Administration of medicine

2.3

177.0

1720

4524

K80

ICPC

Cardiac arrhythmia NOS

3.6

176.6

710

1134

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

176.6

1712

4498

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

+∞

176.6

214

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.5

176.6

1327

3095

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.1

176.3

615

881

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

175.3

2301

6833

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.1

175.0

883

1646

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.9

174.9

984

1960

A46

ICD-10 Finland

Erysipelas

2.6

174.2

1235

2796

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.7

173.6

4663

17404

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

10.9

173.1

260

137

M79.1

ICD-10 Finland

Myalgia

2.1

173.0

2192

6421

N06AX18

ATC

reboxetine; oral

60.5

173.0

159

J01DA01

ATC

[U] cefalexin

1.6

172.2

9195

40708

ZXA00

NOMESCO Finland

Right side

2.0

172.1

2420

7367

A10AD01

ATC

insulin (human); parenteral

409.7

171.4

215

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

9.6

171.3

277

166

B01AB10

ATC

tinzaparin; parenteral

3.0

171.1

943

1855

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

46.5

171.1

163

I35.0

ICD-10 Finland

Aortic (valve) stenosis

28.4

170.8

179

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

170.5

12627

60413

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

3.9

170.3

628

940

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

6.6

169.4

359

315

UKC02

NOMESCO Finland

Cystoscopy

2.7

168.6

1131

2486

I25

ICD-10 Finland

Chronic ischaemic heart disease

34.4

168.3

169

N05BA02

ATC

chlordiazepoxide; systemic

16.1

167.4

209

IBA03

NOMESCO Finland

Psychotherapy evaluation

43.7

167.4

161

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

166.9

7699

32845

R55

ICD-10 Finland

Syncope and collapse

2.8

166.9

1011

2101

F60.5

ICD-10 Finland

Anankastic personality disorder

19.9

165.9

192

N03AX11

ATC

topiramate; oral

5.5

165.6

412

433

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

49.4

165.3

156

PHM99

NOMESCO Finland

Endovenous obliteration of other vein

+∞

165.0

200

HAB40

NOMESCO Finland

Wedge excision of mammary gland

12.1

164.6

234

111

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

+∞

163.4

198

SPAT1139

SPAT

Nutrition survey

5.4

163.0

412

440

ZX114

NOMESCO Finland

Intramuscular

9.0

162.9

274

175

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

6.1

162.5

365

343

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

161.7

196

A10BJ05

ATC

dulaglutide; parenteral

+∞

161.7

196

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

+∞

161.7

196

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

+∞

161.7

196

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

16.0

161.4

202

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.5

161.0

674

1108

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

+∞

160.9

195

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

291.0

160.7

204

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

23.9

160.7

176

K02.1

ICD-10 Finland

Caries of dentine

1.6

160.4

10367

47614

I50.0

ICD-10 Finland

Congestive heart failure

171.6

160.4

209

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

+∞

160.1

194

I50.1

ICD-10 Finland

Left ventricular failure

+∞

160.1

194

C01BC04

ATC

flecainide; systemic

28.9

160.1

167

XF600

NOMESCO Finland

Bloodpressure measurement

3.8

160.0

607

928

S97

ICPC

Chronic ulcer skin

5.7

159.6

381

383

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

11.0

159.5

238

124

Z01.7

ICD-10 Finland

Laboratory examination

2.0

158.3

2055

6061

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

15.8

158.0

199

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.3

158.0

751

1346

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

13.7

157.8

211

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

157.6

191

B01AC24

ATC

ticagrelor; oral

+∞

157.6

191

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

13.8

157.5

210

JHB00

NOMESCO Finland

Hemorrhoidectomy

10.0

157.2

247

141

WX780

NOMESCO Finland

Remote monitoring CPAP

4.0

156.9

559

814

N06AA04

ATC

clomipramine; systemic

25.4

156.8

169

D07AC01

ATC

betamethasone; topical

1.6

156.5

4821

18563

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

22.6

156.3

174

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

24.2

155.8

170

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

155.3

5230

20588

A12AA04

ATC

calcium carbonate; oral

39.4

155.3

152

4549X

ICD-9 Finland

Varicose veins of lower extremities, Without mention of ulcer or inflammation

+∞

155.1

188

R03DC03

ATC

montelukast; oral

1.9

154.9

2481

7882

B01AF01

ATC

rivaroxaban; oral

3.2

154.6

743

1341

C09DA01

ATC

losartan and diuretics; oral

3.3

154.2

718

1269

J01EA01

ATC

trimethoprim; systemic

1.8

154.2

3187

10979

M01AB05

ATC

diclofenac; systemic, rectal

1.5

154.1

9812

44722

L01

ICPC

Neck symptom/complaint

2.0

154.0

2230

6840

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.8

153.9

3357

11751

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

13.0

153.5

210

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.6

153.2

617

986

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

8.8

153.2

261

170

N05AF01

ATC

flupentixol; systemic

33.8

152.8

154

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

+∞

152.6

185

F10.20

ICD-10 Finland

Alcohol dependence currently independent

13.0

152.5

209

B02AA02

ATC

tranexamic acid; systemic

2.0

152.4

2091

6290

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.2

152.3

1633

4465

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

26.8

150.7

160

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

150.6

1679

4663

SPAT1215

SPAT

Assessment of need for medical rehabilitation

4.5

149.9

460

591

M01AH05

ATC

etoricoxib; oral

1.5

149.9

9345

42277

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

10.6

149.9

228

123

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

160.5

149.8

196

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

140.8

149.3

197

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.5

149.2

1165

2762

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

182.9

148.7

193

E05

ICD-10 Finland

Thyrotoxicosis [hyperthyroidism]

8.1

148.7

267

188

WX290

NOMESCO Finland

Other blockage of nerve

1.5

148.2

8562

38057

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

353.7

147.6

186

R00.0

ICD-10 Finland

Tachycardia, unspecified

3.8

146.9

550

832

R01AD12

ATC

fluticasone furoate; nasal

1.6

146.6

5689

23104

Z3229

NOMESCO Finland

Other healthcare associate professional

3.0

146.5

807

1585

SFA10

NOMESCO Finland

One-surface restoration

1.5

145.6

9247

41887

H3601, E103,

ICD-10 Finland

+∞

145.2

176

H3603, E103,

ICD-10 Finland

+∞

145.2

176

N03AF01

ATC

carbamazepine; oral, rectal

4.2

145.1

488

678

R52.9

ICD-10 Finland

Pain, unspecified

2.4

144.5

1226

3023

R03BB04

ATC

tiotropium bromide; inhalant

3.3

144.1

677

1203

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

144.1

2599

8566

J01CA08

ATC

pivmecillinam; oral

1.6

144.0

5953

24511

127

Kela drug reimbursment

Transplant complication

25.8

143.6

154

160

Kela drug reimbursment

exenatide

+∞

143.5

174

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.0

143.5

783

1529

R05

ICPC

Cough

1.7

143.4

3238

11419

C07AB03

ATC

atenolol; systemic

7.4

143.2

274

211

R13

ICD-10 Finland

Dysphagia

3.2

143.1

694

1259

H36.01

ICD-10 Finland

Diabetic maculopathy

342.1

142.7

180

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

5.0

142.2

387

445

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

340.2

141.9

179

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.8

141.7

528

796

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

8.2

141.6

253

177

RD210, ,

NOMESCO Finland

7.5

141.2

268

204

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

17.6

140.9

170

L02BG04

ATC

letrozole; oral

2.9

140.5

812

1640

N17.9

ICD-10 Finland

Acute renal failure, unspecified

10.1

140.4

220

125

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.7

140.3

953

2104

F50.9

ICD-10 Finland

Eating disorder, unspecified

10.1

140.1

219

124

WF049

NOMESCO Finland

Radiotherapy of metastasis

334.4

139.4

176

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

+∞

139.4

169

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

+∞

139.4

169

SPAT1281

SPAT

Other administrative function

2.6

139.4

999

2268

D01

ICPC

Abdominal pain/cramps general

2.0

138.7

1795

5273

SFA20

NOMESCO Finland

Two-surface restoration

1.5

138.6

9900

45765

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

27.7

138.6

146

XKD00

NOMESCO Finland

Uroflowmetry

2.6

138.1

965

2162

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.7

138.0

915

1994

GD1AD

NOMESCO Finland

Thorax CT examination

4.4

137.7

428

556

E87.6

ICD-10 Finland

Hypokalaemia

9.3

137.6

226

139

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.5

137.4

1030

2391

C10AA04

ATC

fluvastatin; oral

4.7

137.4

403

497

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.8

137.3

844

1765

SFA30

NOMESCO Finland

Three-surface restoration

1.5

137.0

6010

25006

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

249.1

137.0

175

A29

ICPC

General symptom/complaint other

2.3

136.6

1303

3384

M70.6

ICD-10 Finland

Trochanteric bursitis

2.4

136.5

1156

2846

D11

ICPC

Diarrhoea

2.0

136.5

1892

5698

SPAT1255

SPAT

Intravenous administration of medicine

3.3

136.0

631

1112

N06AA10

ATC

nortriptyline; systemic

8.6

135.8

234

155

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.7

135.8

3847

14406

A99

ICPC

Disease/condition unspecnature/site

2.5

135.6

1022

2379

H02AB04

ATC

methylprednisolone; systemic

2.1

135.2

1612

4589

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.0

135.0

710

1355

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

28.7

135.0

141

N05AL01

ATC

sulpiride; systemic

33.7

134.9

136

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

3.8

134.8

500

751

R52.2

ICD-10 Finland

Other chronic pain

4.6

134.7

397

492

ZXA05

NOMESCO Finland

Left side

1.9

134.0

2147

6796

N06BA12

ATC

lisdexamfetamine; oral

13.0

132.9

182

SPAT1377

SPAT

Polysomnography

4.4

132.8

418

549

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

+∞

132.8

161

EBA15

NOMESCO Finland

Extraction of multiple teeth

5.5

132.7

327

340

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.4

132.7

592

1016

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.3

132.6

1263

3277

J01FA10

ATC

azithromycin; systemic

1.5

132.1

9923

46136

K04

ICPC

Palpitations/awareness of heart

3.4

132.1

590

1013

G43.9

ICD-10 Finland

Migraine, unspecified

2.4

131.7

1114

2740

C50.99

ICD-10 Finland

Breast, unspecified

44.8

131.5

126

E03.0

ICD-10 Finland

Congenital hypothyroidism with diffuse goitre

944.3

131.5

162

WX723

NOMESCO Finland

CPAP therapy

3.7

131.4

515

806

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

+∞

131.1

159

R20.2

ICD-10 Finland

Paraesthesia of skin

2.5

130.8

1005

2361

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

237.5

130.5

167

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

47.1

130.4

124

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

9.7

130.3

208

122

IGY02, ,

SPAT

17.5

129.9

157

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

6.8

129.7

266

224

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

236.1

129.7

166

M48.0

ICD-10 Finland

Spinal stenosis

2.8

129.4

766

1567

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

161.3

129.2

169

F41.3

ICD-10 Finland

Other mixed anxiety disorders

7.2

128.6

253

202

TAB00

NOMESCO Finland

Lumbar puncture

3.2

128.6

615

1105

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.2

128.6

624

1132

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.5

128.2

973

2271

P15

ICPC

Chronic alcohol abuse

5.8

127.8

300

296

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.0

127.7

1619

4713

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

159.3

127.6

167

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

4.5

127.6

387

492

C09CA03

ATC

valsartan; oral

3.2

127.5

621

1129

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.4

127.2

1040

2516

N03AF02

ATC

oxcarbazepine; oral

4.2

127.2

421

577

XW000

NOMESCO Finland

Bone marrow biopsy

6.7

127.1

263

224

N18.8

ICD-10 Finland

Other chronic renal failure

20.3

127.0

146

E23.05

ICD-10 Finland

Lack of TSH

120.6

126.6

169

C50

ICD-10 Finland

Malignant neoplasm of breast

35.9

126.5

126

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

9.3

126.2

207

127

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

+∞

126.2

153

N05AE04

ATC

ziprasidone; systemic

+∞

126.2

153

K30

ICD-10 Finland

Functional dyspepsia

2.1

125.8

1436

4014

F60.8

ICD-10 Finland

Other specific personality disorders

48.4

125.7

119

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

7.7

125.6

233

172

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

125.5

2345

7787

IGV01

NOMESCO Finland

Psychiatric network contact

301.7

125.5

159

M01AC06

ATC

meloxicam; systemic, rectal

1.6

125.1

4245

16574

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.2

125.1

1271

3388

AA400

NOMESCO Finland

Electroconvulsive therapy

893.1

124.9

154

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

124.8

9541

44283

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.2

124.8

1308

3532

C01BD01

ATC

amiodarone; systemic

444.4

124.7

156

F93.89

ICD-10 Finland

Other childhood emotional disorders

299.8

124.7

158

H02AB07

ATC

prednisone; oral

2.1

123.9

1414

3951

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

297.9

123.9

157

I47.2

ICD-10 Finland

Ventricular tachycardia

44.8

123.2

118

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.1

123.1

642

1218

A10BG03

ATC

pioglitazone; oral

224.5

123.1

158

R60.9

ICD-10 Finland

Oedema, unspecified

3.7

123.1

482

754

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

+∞

122.9

149

C10AA03

ATC

pravastatin; oral

4.4

122.4

380

493

R07.3

ICD-10 Finland

Other chest pain

2.4

122.1

1006

2442

J01FA09

ATC

clarithromycin; systemic

1.6

121.9

4589

18338

3051, ,

Kela drug reimbursment

21.2

121.8

138

JN4CD

NOMESCO Finland

Very extensive body CT

9.7

121.8

195

115

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

9.3

121.7

200

123

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

7.3

121.7

236

185

T85

ICPC

Hyperthyroidism/thyrotoxicosis

14.4

121.6

159

R01AD08

ATC

fluticasone; nasal

1.6

121.4

4369

17275

K59.1

ICD-10 Finland

Functional diarrhoea

3.1

121.4

610

1131

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

4.5

120.9

372

479

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

+∞

120.4

146

OAA65, ,

SPAT

1.7

120.3

3226

11859

K85

ICPC

Elevated blood pressure

2.3

119.7

1104

2821

M02AA07

ATC

piroxicam; topical

1.6

119.6

3763

14400

IHZ05, ,

SPAT

2.9

119.6

668

1321

SPAT1058

SPAT

PEF monitoring instruction

2.5

119.2

892

2066

A08

ICPC

Swelling

4.4

118.8

367

474

A41.9

ICD-10 Finland

Sepsis, unspecified

6.4

118.8

257

231

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

8.3

118.7

209

143

WX722

NOMESCO Finland

PEEP

4.4

118.7

375

494

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

5.0

118.5

324

374

J01CA04

ATC

amoxicillin; systemic

1.6

118.4

13911

70177

SPAT1283

SPAT

Restricted health certificate

1.6

118.1

3720

14234

K86

ICPC

Hypertension uncomplicated

2.8

118.0

705

1449

SPAT1104

SPAT

Monitoring of emergency patient

3.0

117.9

628

1207

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

+∞

117.1

142

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

+∞

117.1

142

AN4

Balloon angioplasty and drug eluding stent

+∞

117.1

142

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

8.1

116.1

208

146

N17

ICPC

Vertigo/dizziness

2.2

115.7

1189

3181

5611

FHL

Vena saphena Magna and / or swarm of nodule and possible local emissions

412.8

115.7

145

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

+∞

115.4

140

A04AD12

ATC

aprepitant; systemic

110.5

115.4

155

LCA06

NOMESCO Finland

Biopsy of endometrium

2.1

115.3

1400

4003

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

115.1

2813

10074

K59.0

ICD-10 Finland

Constipation

3.2

114.9

557

1009

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.7

114.8

443

685

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

114.4

1516

4477

R74

ICPC

Upper respiratory infection acute

1.5

114.2

5970

25528

R4120

NOMESCO Finland

Occupational therapy

3.0

114.2

625

1221

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

3.0

113.7

620

1208

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

47.2

113.7

108

A11

ICPC

Chest pain NOS

2.9

113.6

660

1335

R06.5

ICD-10 Finland

Mouth breathing

2.2

113.4

1177

3161

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

3.1

113.3

588

1112

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

113.2

2920

10605

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.2

113.0

1090

2838

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

10.1

113.0

176

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.8

112.7

664

1354

CK2S4, ,

SPAT

50.2

112.5

106

L02

ICPC

Back symptom/complaint

2.0

112.5

1468

4310

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

28.9

112.2

117

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

6.5

112.2

237

207

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

30.0

112.2

116

F32.0

ICD-10 Finland

Mild depressive episode

4.2

112.2

367

498

R01AD58

ATC

fluticasone, combinations; nasal

1.5

112.2

4343

17405

R03BA02

ATC

budesonide; inhalant

1.7

112.1

2363

8113

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

21.7

112.0

126

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.1

111.7

1226

3368

WX882

NOMESCO Finland

High dependency care

6.4

111.7

241

216

R4110, ,

SPAT

2.5

111.6

854

1999

UJF30

NOMESCO Finland

Ileoscopy through colon

2.3

111.4

1070

2781

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

111.3

5988

25718

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.5

111.3

844

1967

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.6

111.2

780

1748

E83.51

ICD-10 Finland

Hypocalcemia

28.7

111.1

116

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.2

110.7

543

991

L15

ICPC

Knee symptom/complaint

1.7

110.6

2811

10162

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.1

110.6

556

1031

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

+∞

110.5

134

A10AB06

ATC

insulin glulisine; parenteral

+∞

110.5

134

M01AH01

ATC

celecoxib; oral

1.9

110.5

1714

5347

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

6.8

110.4

225

188

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

38.4

109.8

108

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.1

109.7

1198

3284

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

+∞

109.6

133

L08

ICPC

Shoulder symptom/complaint

1.7

109.4

2479

8683

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.9

109.4

615

1220

C02EA02, ,

ATC

57.4

109.2

101

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.5

109.0

328

414

R03BA05

ATC

fluticasone; inhalant

1.7

108.7

2544

8991

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

766.6

108.4

134

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

261.4

108.3

138

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.8

108.3

1943

6351

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.8

108.2

1936

6322

OAB72

NOMESCO Finland

Weight control and weight loss guidance

10.9

108.1

162

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.1

108.1

362

501

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

+∞

108.0

131

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.4

107.6

882

2133

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.3

107.5

484

835

T99

ICPC

Endocr/metab/nutrit disease other

7.5

107.2

204

156

N19

ICD-10 Finland

Unspecified kidney failure

8.9

107.0

180

115

M10.9

ICD-10 Finland

Gout, unspecified

3.8

106.8

399

602

S29

ICPC

Skin symptom/complaint other

1.8

106.8

2161

7323

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

381.2

106.6

134

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.1

106.5

1301

3725

L04AA06

ATC

mycophenolic acid; systemic

8.6

106.4

183

121

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

2.0

106.4

1509

4562

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.9

106.4

588

1155

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.3

106.2

1004

2590

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

13.2

106.1

144

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

747.8

105.9

131

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.4

105.9

858

2064

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

105.6

2940

10871

107

Kela drug reimbursment

Pernicious anaemia

+∞

105.5

128

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

105.5

4268

17230

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

11.1

105.4

156

Z49.1

ICD-10 Finland

Extracorporeal dialysis

51.2

105.4

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

24.9

105.4

114

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

105.1

2787

10174

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

253.7

105.1

134

G04BD12

ATC

mirabegron; oral

2.6

104.9

739

1659

UJH02

NOMESCO Finland

Anoscopy

4.4

104.7

328

429

ZX090

NOMESCO Finland

Other technic of radiotherapy

114.0

104.5

140

J45

ICD-10 Finland

Asthma

2.0

104.2

1365

4009

C05AA08

ATC

fluocortolone; rectal, topical

2.0

104.2

1419

4227

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

9.0

104.1

174

110

C09DA06

ATC

candesartan and diuretics; oral

3.2

104.1

513

939

L13

ICPC

Hip symptom/complaint

1.9

103.4

1621

5068

N05AA01

ATC

chlorpromazine; systemic, rectal

99.7

103.3

140

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.5

103.1

776

1801

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.3

102.9

956

2447

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

12.1

102.6

145

TKC20

NOMESCO Finland

Catheterisation of bladder

3.6

102.5

419

676

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.2

102.5

484

862

4CJ01, ,

NOMESCO Finland

+∞

102.2

124

116

Kela drug reimbursment

Prostate cancer

+∞

102.2

124

F10.24

ICD-10 Finland

Alcohol depence active use

12.7

102.2

141

I42.0

ICD-10 Finland

Dilated cardiomyopathy

246.1

101.8

130

IER01

NOMESCO Finland

Psychoeducation, group

128.2

101.7

135

G03DB01

ATC

dydrogesterone; oral

1.8

101.6

1845

6046

P20

ICPC

Memory disturbance

3.1

101.6

526

993

R96

ICPC

Asthma

2.2

101.6

1024

2714

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

12.1

101.6

144

J01MA14

ATC

moxifloxacin; systemic

2.4

101.3

872

2157

N01

ICPC

Headache

1.8

101.3

1984

6653

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.9

101.2

1659

5263

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

18.5

101.2

120

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

5.7

101.1

241

242

SPAT1284

SPAT

Extensive health certificate

3.9

100.9

363

532

EBA00

NOMESCO Finland

Extraction of tooth

1.5

100.7

5410

23115

C07AA07

ATC

sotalol; systemic

11.2

100.7

148

FN1AD

NOMESCO Finland

CT of coronary arteries

+∞

100.6

122

A12BA01

ATC

potassium chloride; oral

109.9

100.5

135

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

35.5

100.2

100

I49.5

ICD-10 Finland

Sick sinus syndrome

705.6

100.2

124

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

358.2

100.1

126

D06

ICPC

Abdominal pain localized other

2.1

100.1

1192

3377

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.8

100.0

588

1197

IEY01

NOMESCO Finland

Psychoeducation, individual

86.7

99.8

137

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

99.4

3949

15844

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

12.8

99.4

137

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

99.4

602

1246

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

6.3

99.1

216

196

45499

ICD-8 Finland

Varicose veins of lower extremities, Other and unspecified, without ulcer

+∞

98.9

120

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

98.8

3456

13475

I84.5

ICD-10 Finland

External hemorrhoids without complication

6.5

98.8

210

185

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

694.2

98.5

122

N06AX17

ATC

milnacipran; oral

238.4

98.5

126

C07AB12

ATC

nebivolol; oral

5.2

98.5

254

277

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

19.2

98.3

115

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

361

22.14

321.77

6.0

2.1

0.33

0.31

u/ml

0.18

204

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6697

24196

1.91

317.13

3.5

2.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1398

2438

3.44

310.51

1.7

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1422

2511

3.40

310.11

1.8

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

2143

4850

2.71

309.72

1.8

1.4

—

(3019198) Lymphocytes [#/volume] in Blood

9078

27560

2.79

307.65

6.4

4.6

2.00

1.98

e9/l

0.68

8269

25252

(3019060) Gas panel - Arterial blood

813

787

6.07

307.65

6.1

3.1

—

(3001604) Monocytes [#/volume] in Blood

8725

25947

2.79

307.65

6.5

4.7

0.55

0.53

e9/l

15.10

7779

23313

(3015736) pH of Urine

6827

23492

2.05

307.65

3.1

2.2

5.95

5.94

0.01

676

3191

(3044889) 12 lead EKG panel

10588

32117

3.18

307.65

3.3

1.7

—

(3019069) Monocytes/100 leukocytes in Blood

8152

24879

2.59

307.65

6.9

4.8

8.21

8.09

2.86

7681

23606

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5399

12300

3.14

307.65

3.0

1.7

56.47

59.71

u/l

1.30

4992

11440

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6367

12252

4.04

307.65

1.9

1.3

98.28

100.27

pmol/l

2.11

3651

6330

(3018095) Leukocytes [#/volume] in Urine

5417

16198

2.29

307.65

3.7

2.3

61.49

65.35

e6/l

0.20

3785

9761

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1233

1160

6.39

307.65

10.3

5.7

125.47

128.11

g/l

2.58

1202

1118

(3018010) Neutrophils/100 leukocytes in Blood

8369

26194

2.54

307.65

6.3

4.5

55.79

55.21

4.60

7914

24981

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

15328

71761

2.64

307.65

4.8

2.6

2.85

3.06

mmol/l

162.72

14518

68398

(36304419) Bacteria [Presence] in Urine

4056

10852

2.45

307.65

2.9

2.0

—

(3016502) Oxygen saturation in Arterial blood

1329

1235

6.50

307.65

10.1

5.4

96.03

96.46

0.87

1280

1176

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6100

15292

2.92

307.65

3.3

2.1

31.03

28.50

u/l

3.41

5802

14697

(3020630) Protein [Mass/volume] in Serum or Plasma

1038

1318

4.67

307.65

2.8

1.3

66.53

68.67

g/l

11.87

967

1229

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1656

1308

7.80

307.65

3.9

2.7

71.56

66.29

ng/l

0.79

1485

1181

(3033658) Prothrombin time (PT) actual/Normal

3836

8956

2.82

307.65

4.1

2.2

96.24

97.48

2.27

3699

8688

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1471

1494

5.98

307.65

9.5

5.0

5.08

4.96

kpa

3.90

1410

1417

(3026493) Urate [Moles/volume] in Serum or Plasma

4175

11274

2.43

307.65

2.5

1.6

2379.27

3499.17

umol/l

1.39

3749

10415

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8234

13691

5.52

307.65

8.0

3.0

1.21

1.22

mmol/l

39.82

6927

11824

(3009508) Creatinine [Moles/volume] in Urine

5055

6616

5.66

307.65

3.7

1.9

8.17

8.83

mmol/l

10.44

4456

5996

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

15980

70841

4.09

307.65

13.5

5.1

18.15

20.98

mg/l

23.38

12992

48809

(3012544) pH of Venous blood

1370

1601

5.16

307.65

5.0

2.3

7.36

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

425

165

14.90

307.65

3.1

2.3

0.94

0.79

nmol/l

1.70

333

154

(3009466) Valproate [Moles/volume] in Serum or Plasma

454

176

14.94

307.65

6.4

2.8

392.18

391.29

umol/l

0.02

401

147

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2741

2757

6.48

307.65

3.9

1.9

0.82

0.86

mmol/l

22.06

2585

2579

(3002582) Erythrocytes [#/volume] in Urine

4465

11923

2.50

307.65

3.2

2.0

81.77

67.60

e6/l

0.20

3482

8555

(3002032) Base excess in Venous blood by calculation

1338

1546

5.21

307.65

4.9

2.4

1.63

1.90

mmol/l

1.71

1120

1304

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4645

8183

4.00

307.65

2.3

1.8

2.71

2.40

mg/l

18.08

3977

6996

(3026008) Bacteria identified in Urine by Culture

4349

12321

2.32

307.65

2.5

1.8

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4304

1732

18.29

307.65

4.6

2.9

4.58

4.80

pmol/l

10.57

3920

1590

(3018418) pH of Serum or Plasma

5099

7226

5.21

307.65

5.0

1.9

7.39

7.40

1.63

1131

1082

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2185

4199

3.22

307.65

1.9

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1253

1413

5.32

307.65

9.2

4.5

1.35

1.33

mmol/l

0.11

1225

1382

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5287

11079

3.43

307.65

3.2

1.4

41.52

10.65

ng/l

5.37

2732

3503

(3023520) Reticulocytes [#/volume] in Blood

1085

1173

5.51

307.65

2.8

1.8

73.97

65.45

e9/l

8.05

820

855

(40761511) CBC panel - Blood by Automated count

16670

79211

4.82

307.65

13.4

4.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7733

26379

2.18

307.65

2.6

2.0

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

5771

9553

4.60

307.65

3.2

1.4

2.33

2.35

mmol/l

14.35

5276

8514

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

14646

68033

2.31

307.65

4.0

2.4

1.37

1.17

mmol/l

137.77

13838

65175

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2136

3235

4.11

307.65

2.8

1.5

29.84

28.65

12.27

2066

3126

(3001019) Free T4 and TSH panel - Serum or Plasma

2680

5056

3.36

307.65

2.6

1.2

—

(3000991) Gas panel - Venous blood

1231

1337

5.52

307.65

10.7

5.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

8492

26551

2.57

307.65

6.5

4.6

29.75

31.00

22.38

8038

25299

(3013707) Erythrocyte sedimentation rate by Westergren method

12515

42691

3.29

307.65

4.1

2.9

9.71

7.48

mm/h

85.39

11726

40041

(3013512) EKG study

4029

8098

3.35

307.65

3.4

1.7

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4576

8233

3.90

307.65

2.3

1.5

189.71

210.70

u/l

0.45

4331

7779

(3019550) Sodium [Moles/volume] in Serum or Plasma

15992

62607

6.02

307.65

14.4

3.8

139.55

139.80

mmol/l

35.97

15611

60083

(3003396) Base excess in Arterial blood by calculation

1485

1493

6.05

307.65

9.4

4.9

0.74

0.81

mmol/l

0.20

1156

1076

(40758558) Short blood count panel - Blood

4254

10706

2.65

307.65

7.1

3.9

—

(3009343) pH of Capillary blood

1031

1279

4.78

307.65

3.9

2.9

7.41

7.43

2.86

144

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2725

4438

3.93

307.65

2.8

1.5

2.41

2.40

mmol/l

2.28

2409

3788

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1652

2091

4.83

307.65

5.0

2.3

228.38

219.03

u/l

2.32

1576

1980

(3009261) Glucose [Presence] in Urine by Test strip

8416

30414

2.08

307.65

3.5

2.4

0.00

estimate

0.96

1882

5253

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8006

19061

3.53

307.65

2.5

1.9

73.34

75.32

nmol/l

7.26

7477

17895

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

5510

14239

2.73

307.65

1.4

1.2

1.45

1.98

u/ml

2.52

1735

4290

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

11780

50394

1.98

307.65

3.5

2.0

43.07

30.51

u/l

56.34

11229

48564

(3022217) INR in Platelet poor plasma by Coagulation assay

5997

11663

3.90

307.65

9.6

2.0

1.10

1.03

inr

15.05

2045

3802

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1487

967

9.41

307.65

2.5

2.0

5.41

3.38

iu/l

8.35

722

407

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1046

1291

4.81

307.65

3.9

2.9

5.11

5.10

kpa

0.11

1002

1231

(3021960) Folate [Moles/volume] in Serum or Plasma

3497

5554

4.20

307.65

1.5

1.2

19.78

21.41

nmol/l

7.46

3110

4786

(3022096) Basophils/100 leukocytes in Blood

7827

23671

2.57

307.65

6.6

4.8

0.68

0.69

0.51

7332

22300

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1465

1903

4.66

307.65

2.6

2.2

0.22

0.24

g/l

4.49

1367

1798

(3024561) Albumin [Mass/volume] in Serum or Plasma

6680

13111

4.04

307.65

5.1

3.0

36.67

37.87

g/l

50.02

6234

12140

(3019309) Folate [Moles/volume] in Red Blood Cells

2765

3373

5.31

307.65

1.8

1.4

1177.96

1143.42

nmol/l

0.90

2199

2499

(3035637) Corticotropin [Mass/volume] in Plasma

513

250

11.92

307.65

1.8

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1542

1626

5.78

307.65

4.1

1.7

1.22

1.23

mmol/l

8.38

1341

1361

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3695

6043

4.11

307.65

1.7

1.3

36165935.95

50794078.90

pmol/l

0.56

3166

5355

(3020779) Urea [Moles/volume] in Serum or Plasma

1309

1186

6.66

307.65

10.2

3.5

8.23

6.09

mmol/l

22.07

1251

1126

(3044640) Blood type and Crossmatch panel - Blood

5154

14735

2.38

307.65

2.3

1.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7441

11857

5.42

307.65

7.2

2.8

1.21

1.22

mmol/l

28.71

6892

10659

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1342

1564

5.17

307.65

4.9

2.4

5.84

kpa

0.01

1292

1520

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

14907

61326

3.49

307.65

11.6

3.9

91.77

92.51

ml/min/173m2

3.87

12504

47396

(3007164) IgA [Mass/volume] in Serum or Plasma

4561

11938

2.57

307.65

1.5

1.3

2.19

2.13

g/l

1.50

2932

8069

(3006504) Eosinophils/100 leukocytes in Blood

8100

24702

2.59

307.65

6.6

4.7

2.92

2.90

0.34

7626

23378

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

823

797

6.08

307.65

3.4

1.3

114.45

35.97

ng/l

14.00

724

687

(3013650) Neutrophils [#/volume] in Blood by Automated count

9844

29010

3.09

307.65

9.8

4.8

3.94

3.88

e9/l

1.58

8796

25652

(3013826) Glucose [Moles/volume] in Serum or Plasma

9318

23466

3.65

307.65

5.3

2.4

6.63

5.86

mmol/l

151.98

8568

20016

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3973

9317

2.82

307.65

2.1

1.4

1.01

0.79

mg/l

2.48

2920

6672

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

407

23.77

307.65

2.5

1.9

162.88

81.69

ug/min

0.85

278

(3027945) Reticulocytes/100 erythrocytes in Blood

1505

1988

4.59

307.65

3.0

1.9

1.75

1.43

24.48

1341

1774

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

15111

71064

2.46

307.65

4.4

2.6

1.41

1.53

mmol/l

218.23

14327

68208

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2270

2297

6.27

307.65

6.8

3.5

1.06

1.04

mmol/l

1.61

2127

2130

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1011

994

6.04

307.65

2.3

1.2

7.98

3.17

ug/l

5.94

903

859

(3000850) Epithelial cells [#/volume] in Urine

3225

7734

2.66

307.65

2.6

1.8

6.84

6.71

e6/l

0.15

2911

6718

(3026782) Osmolality of Urine

3093

7102

2.77

307.65

2.9

1.9

540.53

576.87

mosm/kgh2o

11.16

2676

5919

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

12374

35939

4.21

307.65

7.6

3.8

74.39

70.53

u/l

23.54

11733

33573

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

14941

63104

3.28

307.65

4.4

2.3

5.85

5.35

mmol/l

286.73

14045

59276

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

14149

54931

3.36

307.65

5.8

2.2

39.26

35.42

mmol/mol

307.65

13382

52108

(3029937) Albumin [Presence] in Urine by Test strip

4794

15141

2.09

307.65

3.8

2.5

0.00

estimate

0.05

1907

5219

(40768797) Stomach Pathology biopsy report

2326

5134

2.80

307.65

1.2

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

2962

7163

2.61

307.65

1.4

1.3

542.10

582.31

titre

0.44

628

1341

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1007

1241

4.81

307.65

3.8

2.9

1.24

1.08

mmol/l

0.63

725

880

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1012

1201

4.99

307.65

8.5

5.2

24.57

24.61

mmol/l

0.14

1004

1196

(3009214) Lutropin [Units/volume] in Serum or Plasma

1497

2417

3.73

307.65

1.5

1.3

8.27

7.77

u/l

0.59

1220

2052

(3001122) Ferritin [Mass/volume] in Serum or Plasma

9654

28266

3.07

307.65

3.5

2.2

90.62

67.88

ug/l

30.27

9120

27009

(3019225) pH of Specimen

1553

2593

3.62

307.65

4.6

2.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

15204

71445

2.52

307.65

4.5

2.6

4.71

4.99

mmol/l

220.55

14448

68533

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

729

681

6.27

307.65

13.0

6.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

1073

1348

4.73

307.65

4.6

2.3

4.78

4.79

kpa

0.03

1032

1312

(3020682) Albumin/Creatinine [Ratio] in Urine

4405

4688

6.76

307.65

4.5

2.1

10.40

16.90

mg/mmol

0.85

2925

2612

(3037467) Urinalysis macro (dipstick) panel - Urine

11091

42089

2.33

307.65

4.2

2.9

—

(3028707) Methadone [Presence] in Urine by Screen method

697

419

9.75

307.65

2.8

1.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

17095

45412

45.27

307.65

10.2

2.0

15.17

14.19

pmol/l

307.65

16556

41532

(3004119) Hemoglobin [Mass/volume] in Venous blood

837

913

5.39

307.65

4.4

1.9

131.53

141.00

g/l

20.16

816

899

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

943

193

29.13

307.65

6.6

1.2

69.47

176.38

u/ml

0.63

383

(3021601) Nitrite [Presence] in Urine by Test strip

8358

30115

2.09

307.65

4.6

3.3

0.00

estimate

2.81

1963

5295

(3021589) Normoblasts [#/volume] in Blood

7842

24000

2.53

307.65

9.9

5.2

0.00

e9/l

0.26

6596

20016

(3030467) Casts [#/volume] in Urine by Automated count

4054

10498

2.54

307.65

3.0

2.0

0.27

0.24

e6/l

0.48

3116

7388

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4244

11698

2.39

307.65

1.8

1.4

1.51

1.23

mmol/l

42.63

3578

10443

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2354

2863

5.21

307.65

2.7

1.6

24.21

27.28

13.46

2008

2499

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2582

3251

5.09

307.65

2.6

1.5

2.45

2.53

g/l

6.44

2362

3027

(3008152) Bicarbonate [Moles/volume] in Arterial blood

826

815

5.96

307.65

8.2

4.1

24.29

24.31

mmol/l

0.04

782

763

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2946

2401

8.13

307.65

2.7

1.6

370.64

382.01

nmol/l

1.49

2708

2251

(3031040) Bacteria [#/volume] in Urine by Automated count

10519

38370

2.37

307.65

4.2

2.8

1526.28

1276.67

e6/l

0.17

151

388

(3023368) Bacteria identified in Blood by Culture

3488

6868

3.34

307.65

4.3

2.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

16034

63040

6.09

307.65

14.5

3.9

3.93

mmol/l

0.31

15621

60280

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8193

18439

3.84

307.65

6.0

2.5

10.10

11.35

umol/l

12.01

7683

17184

(3035350) Ketones [Presence] in Urine by Test strip

8381

30053

2.10

307.65

3.5

2.4

0.00

estimate

0.35

2002

5381

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3861

10669

2.34

307.65

2.3

1.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3062

2939

6.92

307.65

3.2

1.3

840.92

162.97

ng/l

14.95

2434

2101

(3012516) Albumin [Mass/volume] in Urine

4219

4458

6.73

307.65

3.8

1.9

499.84

775.65

mg/l

1.33

2786

2414

(3022948) Iron [Moles/volume] in Serum or Plasma

2858

3853

4.81

307.65

2.6

1.6

14.42

21.85

umol/l

0.81

2650

3635

(40760892) CBC W Ordered Manual Differential panel - Blood

8399

24235

2.84

307.65

6.9

5.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

719

169.48

307.65

8.0

1.3

—

(3013115) Eosinophils [#/volume] in Blood

9056

27191

2.82

307.65

6.7

4.6

0.20

0.19

e9/l

4.47

8159

24654

(3027801) Oxygen [Partial pressure] in Arterial blood

1471

1493

5.99

307.65

9.4

5.0

12.67

14.31

kpa

13.36

1409

1418

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2391

4393

3.40

307.65

3.5

1.5

303.30

37.49

ng/l

7.00

1443

1884

(4035726) Immunohistochemistry procedure

1246

1422

5.26

307.65

1.4

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

14266

64049

2.39

307.65

16.4

5.9

14.46

14.52

0.13

14058

62525

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

17223

58043

38.25

307.65

11.6

2.3

2.47

2.31

mu/l

0.32

16624

54182

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

4850

3623

10.08

307.65

1.3

1.2

218.82

93.66

iu/ml

47.40

2235

1300

(3021387) Prolactin [Units/volume] in Serum or Plasma

1810

3601

3.05

307.65

2.0

1.4

337.43

267.87

mu/l

7.92

1606

3298

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

16632

77719

5.04

307.65

10.9

4.6

27.78

25.47

u/l

32.38

16221

75023

(3006315) Basophils [#/volume] in Blood

8750

25978

2.80

307.65

6.5

4.7

0.04

e9/l

1.63

7784

23316

(3042936) Bacteria identified in Isolate by Culture

2139

4856

2.70

307.21

2.1

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1885

3996

2.87

306.43

2.7

1.9

6.66

6.11

umol/l

0.56

1608

3432

(3005719) IgG [Mass/volume] in Serum or Plasma

1553

2931

3.19

306.00

2.9

2.2

10.59

10.86

g/l

1.72

1415

2693

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2900

7672

2.36

305.34

1.9

1.4

1.43

1.16

77.37

2596

7186

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1542

2903

3.20

304.98

3.1

1.7

—

(40768804) Tissue Pathology biopsy report

6437

23301

1.89

298.37

2.0

1.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

445

234

11.00

297.01

1.2

1.1

2037.28

8.06

iu/ml

0.54

136

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3461

10049

2.18

292.61

1.3

1.2

28.77

29.94

iu/ml

0.06

1050

3446

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

674

654

6.02

292.48

13.0

7.1

24.20

24.28

mmol/l

0.20

657

640

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3310

9476

2.20

289.20

1.3

1.2

9.68

11.50

u/ml

0.75

1441

4220

(3009542) Hematocrit [Volume Fraction] of Blood

17300

89638

7.60

286.97

21.7

7.0

40.67

41.68

6.83

16610

85050

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

656

638

6.00

284.02

1.3

1.2

—

(3007461) Platelets [#/volume] in Blood

17307

89842

7.64

281.07

21.6

7.1

262.38

256.89

e9/l

25.04

17079

87123

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

527

404

7.57

276.73

2.7

1.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1845

4086

2.73

275.94

6.1

2.4

—

(3035941) MCH [Entitic mass]

17310

90072

7.53

272.39

21.5

7.0

30.07

0.09

17185

88743

(3024731) MCV [Entitic volume]

17308

90089

7.45

270.82

21.5

7.0

90.08

89.71

22.90

17184

88748

(3026361) Erythrocytes [#/volume] in Blood

17310

90117

7.49

270.45

21.6

7.0

4.57

4.62

e12/l

41.99

17053

87257

(3017181) Myelocytes/100 leukocytes in Blood

1539

3116

2.96

269.30

4.3

3.8

0.96

0.46

7.59

466

526

(3010813) Leukocytes [#/volume] in Blood

17310

90155

7.45

268.81

21.6

7.1

6.72

6.46

e9/l

45.65

17049

87245

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

757

903

4.91

268.70

5.6

2.4

23.82

24.31

mmol/l

3.43

747

898

(3004588) Protein electrophoresis panel - Serum or Plasma

799

1003

4.67

268.44

2.4

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1897

4338

2.65

266.75

3.2

1.8

11.29

13.78

nmol/l

26.78

1730

4142

(3000963) Hemoglobin [Mass/volume] in Blood

17311

90222

7.43

266.35

21.7

7.1

136.60

138.61

g/l

74.14

17184

88899

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

280

26.79

263.25

1.5

1.1

14.53

13.59

pmol/l

0.88

239

(3027273) Bicarbonate [Moles/volume] in Venous blood

651

709

5.35

253.32

3.7

2.2

25.02

25.41

mmol/l

1.81

623

680

(3010421) pH of Blood

517

435

6.89

252.69

3.5

2.0

7.41

7.42

0.83

474

412

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

947

1445

3.86

251.63

3.6

1.9

26.05

2.22

ug/l

1.18

719

938

(3028026) IgM [Mass/volume] in Serum or Plasma

1196

2160

3.29

250.73

1.8

1.6

1.21

1.27

g/l

0.72

1103

2020

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1079

1831

3.48

247.90

1.6

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1427

2907

2.93

246.36

4.0

3.5

0.66

0.44

1.42

404

484

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2322

6132

2.31

241.01

2.6

1.9

1.03

0.88

e6/l

1.01

1301

3284

(3021440) Promyelocytes/100 leukocytes in Blood

1460

3059

2.85

239.89

4.4

3.8

0.06

0.03

1.57

383

467

(3023323) Follitropin [Units/volume] in Serum or Plasma

1846

4409

2.53

237.00

1.4

1.3

21.07

25.48

iu/l

5.98

1555

3901

(3023183) Ammonium ion [Moles/volume] in Plasma

385

235

9.45

235.57

3.2

2.9

34.54

34.93

umol/l

0.07

361

216

(1616796) Gas panel - Central venous blood

446

339

7.60

235.50

3.3

2.1

—

(3022313) Gas panel - Capillary blood

740

983

4.40

232.86

3.8

3.0

—

(3020891) Body temperature

537

525

5.93

231.08

5.1

3.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

594

653

5.29

228.85

2.1

1.8

1.36

1.09

g/l

7.61

506

566

(3025159) Blasts/100 leukocytes in Blood

1407

2975

2.82

227.06

4.4

3.8

0.05

0.02

0.95

329

400

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

534

531

5.83

226.26

2.6

1.9

465.04

438.90

ug/l

0.07

489

471

(3027315) Oxygen [Partial pressure] in Blood

450

366

7.11

225.76

3.6

2.0

9.01

9.28

kpa

1.63

444

361

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1494

3284

2.72

224.63

2.5

1.8

35.60

42.42

u/l

1.34

1277

2856

(3013290) Carbon dioxide [Partial pressure] in Blood

448

366

7.07

223.97

3.6

2.0

5.04

4.95

kpa

1.16

442

361

(3012501) Base excess in Blood by calculation

448

366

7.07

223.97

3.6

2.0

2.18

1.74

mmol/l

2.22

285

208

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2199

5855

2.28

222.89

2.9

1.9

3.62

3.35

e6/l

0.46

1179

3028

(3018405) Lactate [Moles/volume] in Arterial blood

466

403

6.69

222.66

4.3

2.9

1.31

1.35

mmol/l

0.29

459

398

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

586

664

5.13

218.96

4.5

2.4

51.65

48.50

1.48

576

658

(3019150) Specific gravity of Urine by Refractometry

3624

11961

1.90

208.16

3.8

2.4

1.02

1.01

kg/l

1.47

487

2055

(40761536) Microorganisms panel - Urine sediment

1836

4642

2.38

207.96

3.5

2.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

4993

18303

1.76

204.25

3.0

2.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

464

444

6.04

203.40

2.3

1.6

1.83

1.66

ug/l

0.13

415

380

(3011985) Renin [Units/volume] in Plasma

327

197

9.54

201.62

2.4

1.6

83.23

37.13

mu/l

2.73

301

187

(3048689) Calprotectin [Mass/mass] in Stool

2753

8365

2.02

199.22

2.2

2.9

125.36

118.29

ug/g

0.39

2145

6799

(3011397) Hemoglobin [Presence] in Urine by Test strip

3676

12347

1.86

199.04

3.5

2.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

411

351

6.75

198.30

3.8

2.4

24.06

24.28

mmol/l

0.45

404

346

(3036489) Thrombin time

707

1044

3.95

195.30

2.6

1.6

20.84

20.33

1.90

577

852

(36660697) Celiac disease serology panel - Serum

1888

4966

2.29

195.25

1.2

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

704

1046

3.92

192.92

1.6

1.2

—

(3002256) Pathology report gross observation

2032

5550

2.21

192.32

1.2

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

524

609

4.98

190.60

1.4

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

382

318

6.92

188.08

2.6

1.5

17.21

18.65

5.89

197

127

(3008295) Osmolality of Serum or Plasma

261

125

11.97

182.74

1.9

1.6

286.66

285.24

mosm/kgh2o

0.30

214

104

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

656

963

3.96

182.45

3.9

3.1

24.63

24.57

mmol/l

0.21

616

921

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

515

620

4.81

180.45

6.6

2.7

1.68

1.60

0.55

486

575

(3017143) Hepatitis C virus Ab [Presence] in Serum

3005

9728

1.90

179.82

1.7

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

625

893

4.07

179.80

3.6

1.7

94.11

92.52

0.76

598

835

(3007930) Methemoglobin/Hemoglobin.total in Blood

501

599

4.84

176.83

6.9

2.8

0.93

0.92

0.18

473

558

(3000570) Elastase.pancreatic [Mass/mass] in Stool

510

620

4.76

176.82

1.5

1.2

294.45

343.66

ug/g

4.00

270

310

(3003181) Sodium [Moles/volume] in Urine

258

136

10.87

171.77

1.8

1.6

72.78

76.00

mmol/l

0.22

213

114

(3015171) Extractable nuclear Ab [Units/volume] in Serum

944

1858

2.98

171.16

1.3

1.2

0.90

0.71

u/ml

0.19

118

(3022145) Colonoscopy Study observation

1835

5038

2.18

170.36

1.3

1.4

—

(3021901) Oxygen saturation in Capillary blood

302

209

8.29

170.26

2.7

2.2

—

(40761535) Cells panel - Urine sediment

1226

2818

2.57

167.68

3.4

2.4

—

(3011288) Drugs identified in Urine by Screen method

987

2019

2.87

167.50

2.9

1.5

—

(3000494) Fungus identified in Specimen by Culture

1957

5688

2.06

156.65

1.5

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

694

1188

3.40

156.34

2.0

1.9

0.23

0.22

g/l

4.21

655

1133

(4146454) Self-monitoring of blood glucose

160

29.44

154.04

3.5

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

707

1239

3.32

153.80

2.0

1.8

1.19

1.11

g/l

8.15

668

1185

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

294

232

7.27

150.82

1.6

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

727

1315

3.22

150.70

2.3

1.7

187.34

205.11

pmol/l

3.06

696

1281

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

267

187

8.18

149.29

1.5

1.2

806.35

312.77

pmol/l

0.70

232

167

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1227

2985

2.42

148.97

2.7

1.5

72.56

84.34

ml/min/173m2

14.67

486

848

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

737

1355

3.17

148.92

1.7

1.4

0.46

0.54

nmol/l

0.67

614

1165

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

561

856

3.79

148.19

2.9

2.0

171.19

152.83

4.22

529

795

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

829

1654

2.92

146.53

2.0

39.61

40.94

u/l

1.05

768

1595

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

412

489

4.85

146.45

1.2

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

558

858

3.76

145.89

4.8

2.9

1.36

1.04

mg/l

18.25

523

812

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

626

1052

3.45

144.75

1.8

1.5

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

965

2121

2.66

143.34

1.1

16.72

6.91

u/ml

0.30

(3024928) Oxygen saturation in Venous blood

305

271

6.46

142.38

5.4

1.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

192

13.21

141.24

1.8

3.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

414

517

4.61

139.26

5.3

2.3

1257.29

907.28

iu/ml

0.14

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

620

1064

3.38

139.01

1.5

1.2

17.48

19.61

u/l

0.91

519

902

(3009445) Proteinase 3 Ab [Units/volume] in Serum

709

1330

3.10

138.66

1.6

9.23

12.11

u/ml

0.42

(3047181) Lactate [Moles/volume] in Blood

466

648

4.15

138.39

7.1

2.6

1.31

1.16

mmol/l

2.12

405

569

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

853

1798

2.77

136.77

1.6

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

320

317

5.79

135.85

2.9

1.7

628.47

50947.64

u/ml

0.48

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

312

305

5.87

134.06

4.1

1.6

70.18

22.49

mg/l

0.63

246

250

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

387

473

4.71

133.27

1.8

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

302

289

5.99

132.26

4.0

1.5

1.29

1.15

ratio

0.65

(3034860) Kappa light chains.free [Mass/volume] in Serum

310

308

5.77

131.25

4.1

1.6

39.51

26.43

mg/l

3.90

243

252

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1834

5546

1.97

130.47

2.4

2.1

6545.71

6903.13

u/l

0.17

711

2621

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

713

1412

2.93

127.40

2.1

1.8

—

(3028626) Oxygen [Partial pressure] in Capillary blood

416

564

4.25

127.33

3.9

4.1

9.01

9.29

kpa

1.89

405

553

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

369

457

4.64

125.24

1.9

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

272

246

6.33

125.10

1.5

1.3

0.16

0.11

nmol/l

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1296

3488

2.19

124.60

1.2

1.1

79.00

200.94

titre

2.40

118

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

969

2297

2.47

123.63

2.2

1.5

38.37

43.22

nmol/l

5.34

949

2278

(3007566) Smooth muscle Ab [Titer] in Serum

609

1117

3.16

123.30

1.3

102.76

125.83

titre

0.19

103

(3003694) ABO and Rh group [Type] in Blood

5568

23241

1.52

121.41

1.7

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

273

257

6.08

121.30

1.5

1.3

0.52

0.50

nmol/l

0.20

264

246

(3034770) Mitochondria Ab [Titer] in Serum

591

1078

3.17

120.68

1.3

1020.00

1332.11

titre

0.36

(3039000) Anion gap in Blood

298

315

5.42

119.05

9.4

3.7

11.38

11.50

mmol/l

0.17

273

274

(3018572) Chloride [Moles/volume] in Blood

298

316

5.41

118.69

9.4

3.7

105.85

105.49

mmol/l

0.53

274

275

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

253

224

6.46

118.46

1.5

1.3

—

(3036180) Methadone [Presence] in Urine

169

11.90

118.28

2.0

3.9

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

466

733

3.66

118.06

1.9

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2570

8925

1.74

117.69

1.9

2.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

350

438

4.59

117.43

1.1

1.0

119.89

117.28

0.65

314

374

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

596

1116

3.09

116.72

1.8

1.6

471.54

394.29

titre

0.15

(40760888) Immunoglobulin light chains.free panel - Serum

252

228

6.32

115.87

4.1

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

252

230

6.27

115.01

1.4

1.3

—

nmol/l

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

175

10.40

113.98

3.2

2.3

40603.36

43757.29

ug/l

0.74

175

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

557

1022

3.15

112.64

3.6

1.9

3.59

3.60

g/l

0.09

526

963

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1745

5450

1.90

112.15

4.2

2.5

30.65

32.17

6.56

1353

3965

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

175

103

9.69

109.42

9.0

4.5

11.07

9.00

mg/l

3.72

165

(1001926) Buprenorphine [Presence] in Urine by Screen method

1081

2847

2.22

109.02

2.4

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

269

281

5.48

108.70

1.8

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

405

616

3.78

107.31

2.4

1.2

7.22

6.90

g/l

2.39

380

573

(3010838) Calcium [Moles/time] in 24 hour Urine

407

623

3.76

106.93

2.2

2.0

5.31

5.72

mmol/24h

1.34

368

586

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

541

1007

3.10

106.91

1.3

1.2

462.18

423.41

mg/l

1.14

519

962

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1911

6238

1.82

106.88

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

404

616

3.77

106.69

2.4

1.2

3.53

3.59

g/l

0.43

381

573

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

530

976

3.13

106.53

2.0

2.1

9.36

9.55

mg/l

0.26

500

941

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

404

617

3.77

106.46

2.4

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

468

795

3.39

106.36

2.8

1.9

—

(3016244) Insulin [Units/volume] in Serum or Plasma

285

325

5.02

105.60

2.8

3.7

31.34

26.13

mu/l

0.86

272

303

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

145

12.71

104.88

1.7

1.6

—

(3017732) Neutrophils [#/volume] in Blood

1326

3874

2.01

102.66

2.6

1.6

4.62

4.41

e9/l

0.24

1158

3399

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

494

891

3.20

102.57

1.4

1.2

1833.17

605.45

e6/l

0.48

407

733

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

494

892

3.19

102.39

1.4

1.2

27.24

10.29

e6/l

0.89

388

711

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

638

1346

2.74

101.78

1.3

21.44

32.13

u/ml

0.57

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1376

4095

1.98

101.19

2.3

21.88

20.68

au/ml

0.16

108

551

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

388

600

3.72

100.56

2.4

1.2

2.79

2.72

g/l

0.53

364

557

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

369

552

3.84

99.91

1.1

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

143

11.63

99.04

1.5

1.3

109.33

85.38

nmol/24h

0.93

143

(46235355) HIV 1 and 2 tests - Meaningful Use set

5485

23587

1.46

98.19

2.1

1.9

—

(1617658) Protocol used for examination of sentinel lymph nodes

48.04

98.10

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

359

535

3.85

97.69

1.3

1.2

3.35

3.32

u/ml

0.02

173

232

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

481

882

3.14

97.31

1.2

1.1

3.74

3.45

mmol/l

7.49

452

834

(3037756) Immunofixation for Serum or Plasma

213

195

6.24

96.99

1.9

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

370

570

3.73

96.38

1.2

4.01

3.54

u/ml

0.09

130

195

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

368

565

3.74

96.29

2.5

1.2

9.55

10.18

g/l

2.05

342

521

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1271

3744

1.99

95.99

1.3

46.09

49.32

au/ml

0.17

240

(3000012) Reticulocyte production index

179

134

7.62

95.53

1.9

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

383

611

3.60

95.15

2.7

2.6

—

(3025941) Bacteria identified in Stool by Culture

1228

3609

1.99

93.25

1.3

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

1433

4450

1.89

92.88

1.4

1.3

234.66

248.95

u/ml

0.07

1326

4157

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

341

508

3.85

92.83

2.5

1.3

0.35

0.16

g/l

1.46

310

460

(3030981) Hyaline casts [#/volume] in Urine by Automated count

793

1960

2.35

92.12

3.0

1.8

0.22

e6/l

0.01

772

1879

(1002224) Polysomnography panel

1035

2880

2.10

90.80

1.1

1.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

271

341

4.55

90.40

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1219

3614

1.97

90.26

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

153

100

8.72

89.65

1.7

1.4

5.18

1.48

nmol/l

1.46

129

(4200892) Spirometry reversibility

1063

3011

2.06

89.02

1.4

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

174

138

7.19

88.98

3.6

1.6

44.45

63.11

mg/l

0.38

135

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

579

1247

2.68

88.84

1.3

12.14

12.17

u/ml

0.00

198

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

276

362

4.36

87.83

1.9

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

573

1236

2.68

87.65

1.4

1.3

6.50

10.38

u/ml

0.42

131

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

276

363

4.35

87.55

1.9

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

4818

20572

1.45

87.17

1.8

1.6

—

(3016879) Cocaine [Presence] in Urine

1264

3867

1.91

85.38

2.2

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

241

290

4.75

84.44

1.4

1.2

20.25

14.39

u/l

0.52

217

251

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4555

19354

1.45

83.93

1.8

1.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

239

287

4.76

83.93

3.0

2.0

1.36

1.58

0.30

220

254

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

125

10.94

83.89

2.9

1.4

169.25

107.07

umol/l

0.61

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

507

1050

2.78

83.55

1.5

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

520

1093

2.74

83.43

1.3

46.21

43.22

u/ml

0.12

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

242

296

4.67

83.31

1.6

1.4

72.49

72.14

0.11

226

282

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

547

1184

2.66

83.11

1.3

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

311

470

3.79

83.11

2.3

1.2

0.03

0.00

g/l

0.61

298

446

(3044290) Cell count panel - Cerebral spinal fluid

439

844

2.99

82.24

1.4

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

216

241

5.12

81.88

1.5

1.2

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

237

290

4.67

81.56

1.6

1.4

566.77

522.46

mu/l

0.12

221

276

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

199

205

5.54

81.54

1.6

1.2

—

(3037121) Protein [Mass/volume] in Urine

529

1138

2.68

81.31

3.5

3.0

0.55

0.31

g/l

1.26

244

446

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

264

359

4.21

80.54

1.6

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

235

289

4.65

80.43

1.1

95.11

92.94

0.48

221

263

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

500

1050

2.74

80.34

1.4

1.2

13.94

22.48

u/ml

—

(3026250) Tacrolimus [Mass/volume] in Blood

102

14.86

79.23

37.9

28.6

7.80

6.48

ug/l

3.09

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

517

1115

2.67

79.08

1.3

1.2

261.94

226.61

u/ml

1.76

314

699

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

334

556

3.44

78.16

3.3

2.8

189.56

17.53

u/ml

0.82

281

475

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

294

447

3.76

77.96

1.4

—

(40768795) Lymph node Pathology biopsy report

140

8.05

77.85

1.2

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

257

353

4.16

77.48

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

298

465

3.67

76.33

2.4

1.2

38.42

40.30

g/l

4.37

274

421

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

338

577

3.36

76.25

1.3

1.2

42.86

56.00

titre

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

278

414

3.84

75.75

2.4

1.2

0.00

g/l

0.08

265

391

(3006184) Hemoglobin [Mass/volume] in Capillary blood

355

629

3.24

75.74

2.4

2.0

132.58

136.32

g/l

2.20

278

474

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

276

409

3.86

75.69

2.4

1.2

0.00

g/l

-0.00

265

390

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

288

443

3.72

75.21

1.3

1.2

5.93

6.32

umol/l

0.82

272

417

(43055514) Macroprolactin [Presence] in Serum or Plasma

203

233

4.97

74.79

1.5

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

139

103

7.68

74.79

1.4

1.2

134.12

131.19

nmol/l

0.25

139

103

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

616

1492

2.38

74.62

2.1

1.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

375

702

3.06

73.39

1.5

1.6

0.66

0.76

g/l

1.17

271

551

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

564

1321

2.46

73.32

1.9

1.6

—

(3020876) Protein [Mass/time] in 24 hour Urine

170

166

5.84

73.22

2.6

1.60

1.48

g/24h

0.14

(3000764) Benzodiazepines [Presence] in Urine

1334

4374

1.78

72.17

2.2

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

466

1005

2.67

71.27

1.5

1.2

100.48

107.14

u/ml

0.47

217

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

445

937

2.73

71.15

1.3

2.79

7.61

u/ml

0.69

(3002079) Sodium [Moles/time] in 24 hour Urine

129

7.89

70.79

1.2

1.3

161.61

145.37

mmol/24h

0.92

129

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

255

375

3.89

70.64

2.3

2.2

—

(3028300) Cannabinoids [Presence] in Urine

1342

4444

1.77

70.17

2.2

1.3

—

(3027008) Opiates [Presence] in Urine

1340

4437

1.77

70.08

2.2

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

175

185

5.39

70.01

1.6

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

224

299

4.28

69.90

1.6

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

424

881

2.76

69.45

1.7

1.4

6.60

11.74

iu/ml

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

429

899

2.74

69.19

1.3

1.2

9.51

15.16

u/ml

—

(3023511) Choriogonadotropin [Units/volume] in Urine

879

2544

2.00

69.14

1.4

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

401

812

2.83

68.76

1.4

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

389

775

2.88

68.62

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

247

369

3.82

67.07

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

208

272

4.36

66.50

1.4

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

938

2819

1.93

66.32

1.3

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

172

189

5.19

66.27

1.5

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

653

1712

2.20

66.07

2.3

2.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

147

139

6.02

65.19

2.0

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

147

139

6.02

65.19

2.0

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

147

139

6.02

65.19

2.0

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

192

239

4.58

64.91

3.4

2.7

293.52

14.14

u/ml

1.36

180

219

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1073

3405

1.83

64.32

2.0

1.7

—

(3016038) Potassium [Moles/volume] in Urine

105

9.18

63.75

1.9

1.5

32.97

37.33

mmol/l

0.56

(3024471) HLA-A [Type]

17.48

63.75

1.0

—

(3042733) HLA Ab [Presence] in Serum

17.97

63.55

5.1

2.7

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

419

914

2.63

62.72

3.3

3.4

56.40

56.06

0.21

419

914

(3024139) IgG subclass 3 [Mass/volume] in Serum

256

414

3.53

62.48

1.4

1.3

0.37

0.41

g/l

0.77

170

297

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3686

15757

1.41

62.41

2.2

1.9

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

256

415

3.52

62.27

1.4

1.3

7.05

6.61

g/l

0.85

169

295

(3028192) IgG subclass 2 [Mass/volume] in Serum

256

415

3.52

62.27

1.4

1.3

2.92

3.16

g/l

1.09

170

294

(3024932) HLA-DR beta [Type]

18.26

62.22

1.1

—

(3027944) Amphetamines [Presence] in Urine

1304

4429

1.72

62.19

2.2

1.3

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

412

903

2.62

61.12

3.1

3.4

3.87

3.75

e9/l

0.55

412

903

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3254

13662

1.43

60.71

4.0

2.7

1.51

1.64

ug/l

2.33

2955

12842

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

186

239

4.44

60.70

1.9

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

180

225

4.56

60.60

1.2

60.28

60.87

u/l

0.04

163

204

(4062490) Immunoglobulin typing, IgG

253

415

3.48

60.53

1.5

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

170

202

4.79

60.47

3.9

1.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

101

8.69

59.27

1.2

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

109

7.74

59.11

2.7

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

738

2138

1.99

57.77

1.6

1.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

750

2186

1.98

57.73

1.1

5.19

6.52

u/ml

0.32

112

400

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1236

4235

1.70

56.96

1.1

1.0

—

(3011648) Oxygen content in Venous blood

124

113

6.24

56.81

4.7

2.2

10.98

12.59

2.72

124

113

(3020191) Ethanol [Moles/volume] in Serum or Plasma

176

229

4.38

56.65

1.5

1.2

1.30

1.58

promille

1.10

135

179

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

191

268

4.06

56.20

1.4

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

12.85

56.16

1.9

1.1

184.00

4.30

ug/min

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

349

735

2.72

55.81

1.1

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

4013

17683

1.37

55.64

2.3

2.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

205

307

3.81

55.55

1.1

1.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

155

186

4.74

54.60

1.7

1.4

5.27

5.12

u/l

0.14

125

168

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

260

466

3.19

54.58

1.3

1.1

—

(40768793) Breast Pathology biopsy report

297

578

2.94

54.58

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

260

467

3.18

54.40

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

559

1490

2.16

54.30

1.2

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

159

198

4.57

53.80

2.0

1.2

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

189

274

3.93

53.42

1.7

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

189

275

3.92

53.17

1.7

1.3

—

(3049717) Cytology report of Urine Cyto stain

345

745

2.65

52.68

2.1

2.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

558

1509

2.13

52.29

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

560

1523

2.11

51.74

1.2

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

185

277

3.80

50.19

1.1

1.2

1.06

1.05

ratio

0.20

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

729

2215

1.90

49.73

1.3

1.2

3.43

3.49

ug/l

0.08

684

2123

(40768446) Kidney Pathology biopsy report

7.68

49.68

1.8

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

195

309

3.60

49.04

8.0

1.6

7.70

5.73

mmol/l

7.83

169

238

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

869

2806

1.79

49.00

2.5

1.6

31.02

23.97

u/ml

1.48

838

2713

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

113

111

5.79

48.53

1.4

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

7.10

48.40

1.6

1.4

33.71

42.04

g/l

4.38

(3022689) Creatine [Moles/volume] in Urine

10.24

48.03

1.7

1.5

—

(40768443) Skin Pathology biopsy report

662

1970

1.93

47.99

1.2

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

289

597

2.77

47.92

1.3

48.82

22.02

u/ml

1.02

(3004451) EKG impression Narrative

17.31

47.87

1.2

1.0

—

(3011412) CD3 cells [#/volume] in Blood

204

343

3.39

47.20

2.3

1.29

1.33

e9/l

0.28

176

294

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

184

288

3.64

47.08

1.1

1.0

295.88

284.35

mg/l

0.82

158

268

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

182

284

3.65

46.76

1.2

1.1

1.90

1.69

mmol/l

2.18

169

269

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

7.95

46.49

2.6

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

6.76

46.10

1.6

1.3

2006.16

5048.68

e6/l

1.88

(3017704) Immunofixation for Urine

8.98

45.63

1.7

1.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

372

906

2.35

44.54

1.1

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

141

187

4.29

44.48

1.1

—

(3023419) Bacteria identified in Sputum by Culture

187

309

3.45

44.39

2.8

2.6

—

(3030313) Adrenal Ab [Titer] in Serum

7.31

44.31

1.2

1.1

—

(40768441) Liver Pathology biopsy report

139

183

4.32

44.23

1.3

1.2

—

(3045142) Bone marrow Pathology biopsy report

116

131

5.03

43.62

1.4

1.1

—

(3042517) Benzodiazepines panel - Urine

41.00

43.12

3.8

2.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

6.55

43.08

1.4

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

158

237

3.79

42.83

2.2

2.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

6.29

42.60

1.7

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

7.01

42.44

1.4

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

190

329

3.29

42.14

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

16.38

42.05

1.9

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

10.37

41.87

1.7

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

249

512

2.77

41.68

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

734

2367

1.79

41.50

1.7

—

(3010375) cycloSPORINE [Mass/volume] in Blood

6.50

41.38

23.9

14.8

122.06

121.00

ug/l

0.04

(3016018) Differential panel - Cerebral spinal fluid

226

443

2.91

41.13

1.3

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3755

17018

1.31

41.01

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

6.86

40.26

1.4

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

20.05

39.91

5.6

1.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

133

185

4.09

39.69

2.8

2.2

56.82

54.39

0.60

117

157

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

133

185

4.09

39.69

3.2

1.8

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

131

180

4.14

39.67

1.1

96.87

92.69

0.60

104

132

(21494755) Public health laboratory ask at order entry panel

2096

15731

0.72

39.50

1.3

—

(3019977) pH of Arterial blood

7.34

39.25

3.2

1.5

7.42

7.44

0.72

(3003338) MCHC [Mass/volume]

13599

72128

1.29

39.18

17.7

5.9

333.13

334.06

g/l

27.77

13525

71383

(3045414) Leukocytes [Presence] in Urine

709

2303

1.77

39.12

1.8

1.5

—

(3008898) HLA-B27 [Presence]

902

3136

1.66

39.06

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

122

161

4.31

38.77

1.7

2.0

2.05

1.85

umol/l

1.45

115

154

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

114

142

4.56

38.68

1.6

1.5

7.89

6.26

u/l

0.54

124

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

208

403

2.94

38.64

1.3

1.5

—

titre

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

6.58

38.47

1.6

1.3

13719.91

63690.30

e6/l

0.83

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

102

116

4.99

38.13

1.2

109.78

67.24

u/l

1.58

109

(3005988) Vibrio sp identified in Specimen by Organism specific culture

211

416

2.89

38.06

1.5

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

211

416

2.89

38.06

1.5

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

211

416

2.89

38.06

1.5

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

101

115

4.99

37.71

1.2

41.04

10.20

u/l

1.43

107

(3026389) Candida sp identified in Specimen by Organism specific culture

309

748

2.36

37.55

1.4

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

217

439

2.82

37.44

1.5

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

145

226

3.65

37.41

1.2

20.67

6.39

u/ml

0.52

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

211

422

2.85

37.14

1.5

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

782

2653

1.70

37.07

1.4

—

(3023410) Appearance of Cerebral spinal fluid

219

448

2.79

37.05

1.5

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

135

201

3.82

37.01

1.1

1.99

6.04

nmol/l

0.59

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

253

560

2.58

36.96

1.1

1.50

1.38

g/l

4.16

224

516

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

5.61

36.88

2.3

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

211

426

2.82

36.55

1.5

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

138

211

3.72

36.54

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

5.55

36.50

2.3

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

133

198

3.82

36.48

1.8

1.9

94.16

103.17

1.83

120

177

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2437

10552

1.35

35.72

2.0

1.8

—

(3047189) Immunofixation for 24 hour Urine

10.06

35.39

2.2

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

18.30

35.36

5.9

5.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

8.18

35.07

3.5

2.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

557

1738

1.84

35.01

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

121

174

3.95

34.71

1.2

1.1

—

(3045788) Cell count panel - Pleural fluid

6.59

34.70

1.6

1.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

184

356

2.94

34.32

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

184

356

2.94

34.32

1.2

1.1

—

(40768806) Pleura Pathology biopsy report

6.37

34.23

1.6

—

(3044927) Protein electrophoresis panel - Urine

103

131

4.46

34.19

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

184

357

2.93

34.16

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

182

351

2.95

34.13

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

181

350

2.94

33.80

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

181

351

2.93

33.64

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

117

168

3.96

33.64

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

5.09

33.23

1.4

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

36.18

33.21

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

102

4.95

33.06

3.1

3.0

28.46

27.41

umol/l

0.28

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

155

277

3.18

32.87

2.4

2.3

0.20

0.23

e9/l

1.41

127

229

(3006922) Hepatitis E virus Ab [Presence] in Serum

167

313

3.04

32.84

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

117

172

3.86

32.66

2.8

1.4

—

(21494434) Karyotype in Bone marrow

104

4.86

32.41

1.2

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

6.55

32.17

1.5

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

6.55

32.17

1.5

1.8

—

(3042631) Mycobacterium sp identified in Specimen

137

230

3.39

31.92

2.5

3.0

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

130

211

3.50

31.79

1.3

1.1

69.87

94.18

1.80

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

155

284

3.10

31.63

2.4

2.3

523.29

508.84

e6/l

0.13

125

230

(40757494) Bilirubin.total [Moles/volume] in Blood

5.83

31.33

1.9

2.9

16.08

45.93

umol/l

—

(3012441) Differential panel - Pleural fluid

6.02

31.29

1.6

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1931

8242

1.36

30.66

1.9

1.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

112

4.56

30.65

1.2

31.49

12.06

u/l

1.54

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

4.91

30.57

1.4

1.1

—

(3034426) Prothrombin time (PT)

5.00

30.40

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

218

496

2.50

30.25

1.2

1.1

36.07

40.88

mg/l

0.80

181

407

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

12.90

30.01

1.9

1.1

179417.34

1323081.00

nmol/l

0.82

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

117

4.41

29.89

1.2

89.60

74.59

u/l

0.66

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

108

161

3.81

29.65

1.1

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

209

471

2.53

29.57

1.1

1.0

—

(3000492) Spirometry study

1733

7310

1.38

29.55

1.4

1.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

10.20

29.22

1.6

4.4

2.06

1.22

mmol/l

0.60

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

243

594

2.33

29.01

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

217

503

2.46

29.01

1.1

1.0

—

(3006270) Folate [Moles/volume] in Blood

152

292

2.96

28.77

1.1

400.54

401.17

nmol/l

0.01

139

280

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

47.61

28.74

7.8

1.4

—

(3051651) Icteric interference index of Serum or Plasma

119

4.29

28.65

4.0

2.2

—

(37021550) Renin [Units/volume] in Plasma --upright

8.77

28.48

1.7

1.5

100.11

41.66

mu/l

1.51

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

153

298

2.92

28.31

1.3

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

274

714

2.19

28.26

3.2

2.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

209

484

2.46

28.01

1.1

1.0

224.68

219.75

mg/l

0.13

180

429

(3038071) Oxygen [Partial pressure] in Mixed venous blood

46.47

27.97

7.9

1.4

—

(3017569) Oxygen content in Arterial blood

7.56

27.89

1.8

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

149

289

2.93

27.77

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

170

356

2.72

27.70

1.1

1.0

—

(1761868) Lipid panel - Serum or Plasma

6540

32744

1.21

27.42

2.7

1.8

—

(3000330) Specific gravity of Urine by Test strip

574

1945

1.69

27.34

2.9

2.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

174

373

2.65

27.16

1.1

1.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

149

293

2.89

27.14

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

573

1950

1.68

26.86

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

173

372

2.65

26.85

1.2

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

109

177

3.50

26.71

1.7

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

7.71

26.68

1.3

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

110

180

3.47

26.67

1.7

1.5

1039140.00

368883.13

iu/ml

—

(3051611) Lipemic interference index of Serum or Plasma

133

247

3.06

26.64

3.5

1.9

—

(3036782) Glucose [Moles/volume] in Pleural fluid

110

4.28

26.38

1.4

1.2

5.88

5.13

mmol/l

2.46

100

(3045424) Erythrocytes [Presence] in Urine

309

869

2.03

26.32

1.5

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

10.52

25.77

2.4

1.7

1184.78

1564.15

e6/l

0.11

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

100

157

3.62

25.69

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

931

3600

1.49

25.42

1.8

1.3

4.08

3.19

mg/l

2.17

737

2132

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

338

998

1.93

25.17

1.5

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

12721

67958

1.21

25.17

3.8

3.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

143

288

2.82

25.04

1.2

17.91

7.60

u/ml

0.41

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

177

401

2.51

24.86

1.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

7.16

24.77

3.9

1.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

7.16

24.77

3.9

1.7

—

(40765096) Chromosome analysis panel by Banding

8.93

24.63

1.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

619

2202

1.61

24.48

1.4

1.3

—

(40768800) Prostate Pathology biopsy report

127

242

2.98

24.44

1.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

9.78

24.11

4.0

4.2

43.64

13.00

ug/min

2.82

(3022493) Free Hemoglobin [Mass/volume] in Plasma

106

4.17

24.11

14.2

1.2

2505.90

15075.79

mg/l

1.13

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

5.24

24.10

2.7

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

5.24

24.10

2.7

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

144

298

2.75

24.04

1.2

32.00

64.15

u/ml

0.75

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.97

23.99

1.5

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.97

23.99

1.5

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

130

3.80

23.90

1.0

45.11

47.06

ng/l

0.10

101

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

100

166

3.42

23.80

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

145

303

2.72

23.79

1.2

49.92

22.77

u/ml

0.55

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

144

300

2.73

23.76

1.2

55.67

31.85

u/ml

0.45

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

131

3.77

23.67

1.0

313.34

337.91

ng/l

0.24

104

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

131

3.77

23.67

1.0

883.12

701.98

ng/l

1.93

100

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

156

343

2.59

23.28

1.3

174.86

223.45

titre

0.28

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

156

343

2.59

23.28

1.3

104.00

276.36

titre

—

(3035880) pH of Pleural fluid

7.61

23.23

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

9.53

23.12

1.2

1.4

38.79

37.83

ng/l

0.02

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

133

270

2.80

23.00

1.5

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

590

2110

1.60

22.85

1.6

29.61

0.52

iu/ml

0.49

112

399

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2468

11328

1.27

22.78

3.6

2.6

22.46

22.50

0.05

902

3898

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

117

222

2.99

22.71

1.9

2.0

128.11

107.61

2.31

111

214

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

8.09

22.55

1.4

1.3

338.73

266.77

pmol/l

0.82

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.81

22.51

2.7

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

4.61

22.51

1.7

1.2

3532.57

2671.00

u/ml

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

8.61

22.31

1.2

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

+∞

22.23

1.6

0.0

509.34

—

nmol/l

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

6.34

22.07

1.5

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

10.13

22.02

1.1

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

10.13

22.02

2.1

1.5

2931.84

20331.50

e6/l

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

107

197

3.08

21.82

1.1

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

302

903

1.91

21.75

1.7

1.6

9453.69

10355.08

e6/l

0.20

233

676

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

160

3.33

21.62

1.4

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

276

804

1.96

21.44

1.2

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

180

442

2.32

21.42

1.3

1.46

3.46

u/ml

1.90

249

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

+∞

21.41

7.6

0.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1170

4873

1.38

21.33

1.4

1.5

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

9.01

21.15

1.7

1.2

13.20

10.63

g/l

0.40

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

147

330

2.53

21.11

1.1

1.05

1.01

u/l

0.34

127

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

160

3.30

21.07

2.4

2.6

51.73

50.70

umol/l

0.11

154

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1796

12711

0.78

20.82

1.7

1.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

425

1434

1.69

20.64

1.6

1.4

84.53

45.13

pmol/l

3.50

408

1393

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

154

3.32

20.56

1.2

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

3571

17248

1.21

20.42

1.8

1.7

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

169

413

2.33

20.35

2.0

1.5

25.81

27.84

mg/l

0.16

107

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

4.19

20.24

1.1

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

114

3.73

20.22

1.1

—

(3044007) Cell count panel - Peritoneal fluid

10.62

19.93

1.9

1.6

—

(3000060) B lymphocytes [#/volume] in Blood

132

3.48

19.87

2.0

2.1

198.51

215.77

e6/l

0.15

(3023420) DNA double strand Ab [Units/volume] in Serum

220

611

2.05

19.50

1.8

1.6

24.75

28.04

iu/ml

0.14

(3022621) pH of Urine by Test strip

893

3605

1.42

19.48

2.7

2.1

—

(4034850) Laboratory test

479

1698

1.61

19.28

10.6

4.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

128

281

2.59

19.25

1.5

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

159

3.18

19.09

1.1

—

(44813793) Dust mix specific IgE antibody measurement

184

481

2.17

19.01

1.0

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

103

203

2.88

18.85

2.5

2.9

44.48

43.12

0.26

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

4.37

18.66

1.9

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

192

2.93

18.62

1.1

1.2

0.30

0.29

g/l

0.49

153

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

355

1181

1.71

18.19

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

6.33

17.86

1.7

1.5

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

113

3.51

17.45

1.3

1.1

10.30

4.55

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

403

1406

1.63

17.32

1.1

3.18

3.36

u/ml

0.10

213

866

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

182

2.90

17.26

1.3

1.1

—

(3033799) Differential panel - Peritoneal fluid

8.64

17.09

2.5

1.6

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

180

2.90

17.09

1.1

1.2

108.59

107.06

0.18

159

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

4.29

17.04

1.0

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

6.37

17.02

2.2

3.4

—

11.51

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

4.83

16.83

1.3

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.99

16.81

1.5

1.1

126.11

108.45

nmol/l

0.37

(3016273) Islet cell 512 Ab [Units/volume] in Serum

22.64

16.70

1.1

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

260

810

1.83

16.64

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

202

2.75

16.64

3.5

4.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

283

908

1.77

16.47

2.5

2.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1234

8898

0.77

16.32

1.4

1.3

—

(3014271) Vancomycin [Susceptibility]

4.65

16.21

2.3

1.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

187

525

2.02

16.20

1.2

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

11.83

16.15

1.1

1.0

—

mmol/l

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

4.72

16.10

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

107

237

2.56

15.90

2.2

1.3

187.52

183.21

u/l

0.48

107

237

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

462

1703

1.55

15.84

1.5

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

540

2061

1.50

15.77

2.1

2.4

5.34

5.28

umol/l

0.06

389

1525

(3005082) Progesterone [Moles/volume] in Serum or Plasma

300

994

1.72

15.67

1.4

1.3

29.02

34.47

nmol/l

2.60

272

949

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

125

3.22

15.65

1.2

1.3

68.75

147.69

titre

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.78

15.59

1.3

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

479

1790

1.53

15.45

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

277

903

1.75

15.32

1.7

1.8

6146.67

3646.22

titre

—

(3021788) Differential panel - Synovial fluid

238

742

1.82

15.25

1.6

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.47

15.21

1.5

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

152

2.95

15.15

1.2

1.1

104.57

113.91

0.89

137

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

6.50

14.92

1.3

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

121

3.19

14.77

1.9

2.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

865

3645

1.36

14.66

1.4

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

116

3.22

14.62

1.7

1.6

0.18

0.31

nmol/l

1.14

(3019420) Tryptase [Mass/volume] in Serum or Plasma

127

319

2.26

14.53

1.2

1.7

5.97

8.37

ug/l

0.83

113

286

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

6.53

14.50

2.5

2.0

66.03

43.76

pmol/l

0.50

(3001186) Copper [Moles/volume] in Serum or Plasma

3.55

14.50

1.4

1.3

17.85

16.43

umol/l

0.65

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

150

2.91

14.48

1.1

90.58

96.10

0.66

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

138

360

2.18

14.46

1.7

1.5

41.04

41.27

0.02

241

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

8.32

14.39

1.0

61.42

32.66

mg/l

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

356

1263

1.61

14.39

1.2

1.1

17.02

12.01

au/ml

0.46

106

(3001556) Androgen free Index in Serum or Plasma

112

3.24

14.28

1.4

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

5.84

14.10

2.4

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.60

14.01

2.3

2.4

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

+∞

13.99

1.2

0.0

52.53

—

nmol/l

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

160

2.80

13.91

1.2

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

157

2.82

13.89

1.4

12.18

20.46

u/ml

1.25

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

145

2.89

13.80

1.2

1.1

89.51

99.54

1.10

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

108

260

2.36

13.61

1.1

—

(3028433) Virus identified in Specimen by Culture

116

3.13

13.55

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

6.34

13.23

3.1

1.2

6.53

5.58

mmol/l

0.65

(3029075) Extractable nuclear Ab panel - Serum

121

3.04

13.21

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

129

341

2.15

13.14

2.8

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

926

4016

1.32

12.96

1.3

243.75

234.52

miu/ml

0.31

454

2134

(3033923) Metanephrine [Moles/time] in 24 hour Urine

6.10

12.81

1.1

0.69

0.73

umol/24h

0.14

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.41

12.81

2.4

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

213

2.45

12.62

1.9

1.7

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

117

3.00

12.35

1.5

1.7

9.31

8.16

ug/l

1.16

117

(3044941) Cell count panel - Synovial fluid

187

580

1.83

12.28

1.4

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

329

1192

1.57

12.26

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.36

12.07

1.1

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

4.79

12.06

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

7.23

12.03

1.1

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

6.43

11.96

1.8

1.3

23.58

20.61

g/l

0.23

(3017315) Amylase [Enzymatic activity/volume] in Urine

195

2.47

11.91

1.2

1.1

313.24

369.32

u/l

0.14

187

(3045683) HLA typing for celiac disease panel - Blood or Tissue

171

522

1.86

11.82

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

137

388

2.00

11.74

1.1

1.0

1571.82

1374.59

miu/ml

1.09

137

388

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

798

3438

1.33

11.72

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.40

11.57

1.1

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

320

1169

1.56

11.54

1.2

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

+∞

11.52

1.3

0.0

123.25

—

nmol/l

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

5.90

11.13

2.0

1.6

—

(3048879) Bone marrow aspiration report

6.17

11.11

2.4

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

236

812

1.65

10.89

1.1

—

2.28

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1778

8506

1.20

10.67

2.6

2.1

0.62

0.68

ug/l

2.34

1018

3831

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

310

1146

1.54

10.65

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

14.15

10.51

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

160

2.51

10.37

1.1

1.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

163

513

1.80

10.30

1.8

1.6

47.29

47.63

0.03

360

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.01

10.27

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.12

10.26

1.1

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

109

2.86

10.17

1.1

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

16.98

10.09

1.0

—

(3020491) Glucose [Moles/volume] in Blood

144

439

1.86

10.07

1.8

1.3

6.30

5.21

mmol/l

3.83

101

355

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.43

9.95

1.5

1.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.95

9.94

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

339

1299

1.48

9.88

2.3

1.9

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

6.66

9.85

1.3

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

132

2.62

9.66

3.1

2.6

—

(4281824) Cell count and differential, peritoneal fluid

123

363

1.92

9.50

1.2

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

225

2.19

9.48

1.2

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

6.29

9.41

1.4

1.2

36.22

155.60

ug/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

328

1262

1.48

9.40

1.1

—

(3024263) Appearance of Synovial fluid

180

2.33

9.27

1.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

4.60

9.16

2.4

1.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

163

534

1.73

9.08

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.89

8.75

4.4

4.7

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

9.77

8.64

2.7

1.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

119

2.57

8.32

1.5

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

175

2.27

8.30

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

243

2.05

8.21

1.1

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

4.09

8.05

1.9

1.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.40

8.05

1.1

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

174

2.25

8.04

1.1

114.71

293.20

ng/l

0.51

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.94

8.03

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.94

8.03

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.94

8.03

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.94

8.03

1.2

1.1

—

(3002619) Bacteria identified in Specimen by Culture

3.02

8.00

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

232

860

1.53

8.00

1.6

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.61

7.97

1.4

119.08

76.30

ng/l

0.93

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

374

1526

1.39

7.90

1.3

—

(3007463) Buprenorphine [Presence] in Urine

15.84

7.79

3.9

4.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.04

7.65

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

3.69

7.64

1.3

—

(3019174) dRVVT (LA screen)

3.69

7.64

1.3

1.2

—

(3017509) Phencyclidine [Presence] in Urine

2.80

7.41

1.7

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

+∞

7.41

5.2

0.0

536.44

—

umol/l

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

+∞

7.41

3.9

0.0

1.50

—

g/l

—

(3026726) Creatinine [Moles/volume] in Specimen

8.74

7.39

3.3

1.3

570.53

862.91

umol/l

0.29

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

239

1.99

7.30

1.6

1.5

2.67

2.98

u/field

0.11

170

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

111

2.50

7.21

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

108

337

1.82

7.17

1.1

6.17

14.37

u/ml

2.09

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

9.05

7.11

1.8

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.76

7.09

1.2

1.1

76.92

99.31

0.70

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

8.01

7.07

2.9

1.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

148

510

1.65

6.97

1.1

7.18

7.36

iu/ml

0.03

146

(3010144) Erythrocytes [#/volume] in Synovial fluid

113

361

1.77

6.97

1.4

115980.94

41227.85

e6/l

0.57

243

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

144

493

1.66

6.96

1.4

1.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.40

6.63

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

113

2.41

6.57

1.2

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.66

6.49

1.2

1.1

65.09

95.14

0.92

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

312

1.80

6.42

1.7

1.6

2.34

2.21

u/field

0.07

151

(3013166) Neutrophils/100 leukocytes in Synovial fluid

2.51

6.42

1.3

37.53

52.16

1.43

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.72

6.39

1.1

1.0

—

(3013466) aPTT in Blood by Coagulation assay

3.96

6.31

1.1

35.85

35.91

0.02

(3032352) Blasts [#/volume] in Cerebral spinal fluid

10.51

6.27

4.5

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

536

2393

1.27

6.21

1.1

2.16

2.70

u/ml

0.58

260

1246

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.27

6.08

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

6.01

5.99

4.8

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

340

1434

1.35

5.97

1.4

1.5

7.07

6.15

mmol/l

6.72

312

1289

(40761995) Spermatozoa Progressive [#/volume] in Semen

415

0.41

5.88

3.1

3.5

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

415

0.41

5.88

6.1

7.0

—

(3025577) Chromium [Mass/volume] in Blood

149

2.13

5.86

1.9

2.1

2.58

2.66

ug/l

0.04

131

(3025018) Bordetella pertussis Ab [Titer] in Serum

135

478

1.60

5.80

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

5.76

1.3

0.0

—

(3026470) Cobalt [Mass/volume] in Blood

154

2.10

5.75

1.9

2.1

2.41

2.81

ug/l

0.28

145

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

4.37

5.73

1.5

1.1

1.36

5.45

ml/s/173m2

0.54

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

4.37

5.73

1.0

23.18

10.55

u/l

0.36

(3034891) Synovial lining cells/100 cells in Synovial fluid

197

1.95

5.72

1.8

1.4

6.18

4.94

0.17

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

687

4697

0.82

5.70

1.9

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.64

5.61

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

8.17

5.59

2.5

4.9

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

482

2154

1.27

5.59

1.1

6.23

6.41

u/ml

0.07

259

1227

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.88

5.59

1.6

1.4

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.88

5.59

1.8

1.6

0.96

1.81

mg/l

0.72

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.46

5.58

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

131

2.16

5.46

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

297

1248

1.35

5.39

3.7

2.3

24.51

26.30

mg/l

0.38

179

747

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

163

2.01

5.32

1.2

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

7.35

5.29

1.7

1.0

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.83

5.26

1.8

1.5

1.82

3.83

mg/l

0.88

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.83

5.26

1.8

1.5

1.98

2.04

mg/l

0.02

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.83

5.26

1.8

1.5

2.83

5.95

mg/l

1.34

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.83

5.26

1.8

1.5

0.77

2.19

mg/l

1.31

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.83

5.26

1.8

1.5

0.88

3.51

mg/l

2.08

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.83

5.26

1.8

1.5

1.21

1.48

mg/l

0.14

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.83

5.26

1.8

1.5

0.81

1.25

mg/l

0.32

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.83

5.26

1.8

1.5

1.14

4.14

mg/l

2.12

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.83

5.26

1.8

1.5

0.46

1.30

mg/l

1.36

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

164

2.00

5.24

1.2

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

164

2.00

5.24

1.2

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.47

5.18

2.7

2.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2684

13892

1.11

5.17

1.5

1.4

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

127

2.14

5.14

2.7

1.4

106.11

95.83

ng/l

0.17

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

127

2.14

5.14

1.3

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

120

2.17

5.10

1.3

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

11.31

5.07

1.6

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

11.31

5.07

1.0

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.11

5.05

2.3

2.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

417

1856

1.28

5.04

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.45

5.04

2.1

1.6

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

3.02

5.01

1.6

1.5

1.44

1.69

ug/l

0.49

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

7.54

4.99

2.6

4.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

7.54

4.99

1.3

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

+∞

4.94

1.0

0.0

—

(3008717) Parietal cell Ab [Titer] in Serum

+∞

4.94

1.2

0.0

1411.67

—

titre

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

+∞

4.94

1.0

0.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

455

2054

1.26

4.90

1.1

1.01

1.21

u/ml

0.29

196

950

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

100

2.26

4.90

1.0

0.00

0.13

u/ml

0.56

(3003740) Influenza virus B Ag [Presence] in Specimen

416

1858

1.27

4.90

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

6.13

4.76

1.5

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.83

4.72

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.51

4.70

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.04

4.65

1.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

3.23

4.65

1.2

1.1

48.45

80.13

1.53

(3039443) Prostate specific Ag panel - Serum or Plasma

233

1766

0.74

4.63

1.6

1.5

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

5.28

4.61

1.1

1.2

1.35

2.77

mmol/l

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.50

4.53

1.2

1.1

0.77

36.43

mg/l

0.49

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

151

1.95

4.43

1.1

—

(4212803) Bone marrow aspirate examination

10.18

4.42

1.0

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

6.91

4.41

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.40

4.35

1.3

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

137

523

1.48

4.33

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

159

626

1.44

4.31

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.66

4.21

1.1

1.54

1.26

umol/24h

0.63

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.07

4.12

1.8

1.2

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

+∞

4.12

1.0

0.0

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

+∞

4.12

2.4

0.0

213.80

—

nmol/l

—

(40758292) HTLV I+II Ab panel - Serum

2.31

4.02

1.5

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.83

4.00

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.33

3.96

1.3

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

118

2.01

3.95

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

5.66

3.91

1.8

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

2.56

3.85

1.3

—

(3020650) Glucose [Presence] in Urine

208

1.71

3.67

1.4

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.64

3.57

1.7

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

127

1.92

3.56

2.8

2.4

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

7.54

3.48

3.0

7.7

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

4.24

3.42

1.0

0.05

0.01

u/ml

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.50

3.41

1.2

1.0

—

(3022475) Manganese [Moles/volume] in Blood

3.50

3.41

1.5

1.3

—

(3025130) Human papilloma virus identified in Specimen

339

1551

1.24

3.38

1.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

181

764

1.34

3.36

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

191

814

1.33

3.33

1.4

1.3

305.53

198.37

pmol/l

0.37

191

814

(3036670) Protein [Mass/volume] in Synovial fluid

2.08

3.32

1.6

1.2

37.64

42.87

g/l

1.06

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.75

3.31

1.2

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.75

3.31

1.1

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.16

3.29

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

6.46

3.21

6.3

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

3.17

3.21

1.0

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

124

496

1.42

3.20

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

365

1695

1.22

3.19

1.1

6.47

5.55

u/ml

0.20

143

744

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

4.71

3.18

1.0

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

7.92

3.17

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.51

3.14

2.1

1.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.75

3.12

1.2

1.3

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.77

3.10

1.0

0.03

0.04

u/ml

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

5.09

3.07

1.8

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

176

752

1.33

3.05

1.1

0.63

5.17

u/ml

1.34

245

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

4.35

2.99

1.3

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

445

2121

1.19

2.99

1.1

1.88

2.63

u/ml

0.75

217

1070

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.67

2.98

1.2

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

5.65

2.97

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

298

1.52

2.97

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

137

567

1.37

2.93

1.4

1.5

5.41

4.96

mmol/l

4.48

125

547

(3014133) Dog dander IgE Ab [Units/volume] in Serum

386

1820

1.20

2.93

1.1

3.65

5.29

u/ml

1.18

182

915

(3049233) Organic acids panel - Urine

6.60

2.89

1.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

211

1.61

2.85

1.1

0.39

6.17

u/ml

0.81

189

(40757373) Influenza virus identified in Isolate

2.39

2.72

1.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.23

2.67

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.12

2.66

1.1

1.4

28.94

46.41

mg/l

1.12

(3032868) Hemoglobin electrophoresis panel in Blood

2.24

2.64

1.8

1.5

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.51

2.54

1.1

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.93

2.54

9.8

2.2

—

(3015183) Erythrocyte sedimentation rate

124

519

1.35

2.53

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.53

2.51

5.1

2.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.31

2.44

1.3

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

4.95

2.44

1.0

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.64

2.44

1.0

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

2.45

2.42

1.5

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

172

761

1.28

2.39

1.0

1.1

3.38

7.18

u/ml

0.43

196

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.11

2.38

3.0

2.7

42.13

47.27

umol/l

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

3.64

2.37

1.3

1.0

36.51

35.65

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

310

1468

1.20

2.33

1.1

1.0

0.60

0.47

u/ml

0.10

345

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

403

1.38

2.27

1.8

2.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.63

2.25

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.97

2.24

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.39

2.23

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.71

2.20

1.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

1.94

2.17

1.0

1.1

0.42

1.70

u/ml

0.44

(3033093) Yersinia sp IgM Ab [Titer] in Serum

4.85

2.12

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

4.85

2.12

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

4.85

2.12

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

4.85

2.12

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

4.85

2.12

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

4.85

2.12

2.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

161

720

1.27

2.10

1.0

1.1

0.32

1.14

u/ml

1.01

167

(3006462) Nitrate [Presence] in Urine

276

1.44

2.08

2.7

2.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.48

2.07

1.0

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.45

2.00

1.2

1.3

7.22

7.30

mmol/l

—

(3029612) Listeria sp Ab [Titer] in Serum

2.45

2.00

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

132

1.63

1.99

1.1

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.73

1.95

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

477

3052

0.88

1.95

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.83

1.94

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

245

1.43

1.85

2.4

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.26

1.85

1.0

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.26

1.85

1.1

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

130

577

1.28

1.85

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.18

1.82

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

147

665

1.25

1.80

1.6

1.4

—

(3018291) Platelet Ab [Presence] in Serum

4.71

1.80

1.4

1.5

—

(3040893) Potassium [Moles/volume] in Capillary blood

3.77

1.77

3.0

3.4

4.23

4.29

mmol/l

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

335

1.35

1.73

1.2

1.1

—

(3001729) Color of Synovial fluid

2.69

1.72

1.4

1.2

—

(3005033) Fetal Nuchal fold Thickness US

784

4843

0.91

1.72

1.4

1.5

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.83

1.70

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

787

4856

0.91

1.69

1.4

1.5

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

103

1.65

1.68

1.4

44.14

42.91

0.06

(3033942) Copper [Moles/time] in 24 hour Urine

2.57

1.67

1.4

1.0

2.88

0.30

umol/24h

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

1.83

1.65

4.1

1.5

16.08

3.06

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

146

669

1.24

1.63

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

4.04

1.62

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.46

1.61

1.2

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

311

1.35

1.59

1.1

4.46

22.39

u/ml

0.92

205

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

365

1.32

1.59

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

173

1.47

1.58

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.89

1.56

1.6

1.5

0.39

0.38

ug/l

0.02

(3016135) IgD [Mass/volume] in Serum

3.08

1.49

1.2

26.98

70.84

mg/l

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

807

4938

0.92

1.47

1.5

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.53

1.46

1.0

1.80

2.75

—

(3036071) Salmonella sp Ab [Titer] in Serum

264

1.35

1.41

1.0

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.67

1.38

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.83

1.37

1.2

1.0

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

2.51

1.33

1.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

2.14

1.33

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

3.14

1.33

2.8

2.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.14

1.33

1.2

1.0

—

(40762814) Titanium [Mass/volume] in Blood

1.89

1.32

2.3

2.6

3.42

8.28

ug/l

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.93

1.32

1.1

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.93

1.32

1.0

1.2

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

125

1.49

1.29

1.0

1.1

0.04

1.01

u/ml

0.93

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

125

1.49

1.29

1.1

0.07

0.81

u/ml

0.79

(3016031) Almond IgE Ab [Units/volume] in Serum

1.64

1.26

1.0

0.12

1.08

u/ml

2.84

(3017958) Strawberry IgE Ab [Units/volume] in Serum

2.17

1.25

1.0

0.01

0.16

u/ml

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

111

512

1.23

1.24

1.3

1.4

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

227

1.35

1.22

1.1

0.56

14.10

u/ml

2.24

163

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

161

1.41

1.18

1.1

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.70

1.17

1.1

1.2

11.44

28.20

u/ml

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.57

1.10

1.2

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

367

1.25

1.09

1.1

1.0

11.89

13.71

u/ml

0.21

232

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

121

572

1.20

1.09

1.2

1.3

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.20

1.06

1.0

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.59

1.06

1.0

0.22

4.93

u/ml

1.36

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

137

1.40

1.02

1.3

1.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

335

1.25

1.02

5.8

6.8

1178.25

9963.30

u/ml

0.52

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.62

1.01

1.1

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

109

1.45

1.01

1.8

1.4

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

2.08

1.01

1.0

1.1

—

2.20

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.63

0.99

1.4

1.8

0.47

0.75

u/field

0.63

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

119

1.43

0.99

1.1

0.19

0.55

u/ml

0.83

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

850

4525

1.07

0.98

1.5

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

2.26

0.94

1.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

2.26

0.94

2.0

1.2

2.00

4.17

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

121

1.40

0.92

1.0

0.03

0.26

u/ml

1.38

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.97

0.90

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

121

592

1.16

0.79

2.7

3.2

—

(3051101) Glucose [Moles/volume] in Cord blood

1.98

0.77

5.0

1.5

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

2.17

0.76

1.0

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

431

0.83

0.76

3.4

3.5

7.24

8.66

mg/l

1.18

354

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

275

1699

0.91

0.75

1.6

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1007

5953

0.95

0.74

1.4

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1005

5938

0.95

0.73

1.4

1.5

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.40

0.73

1.1

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1011

5967

0.96

0.71

1.4

1.5

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.40

0.70

1.1

4.17

10.46

u/ml

1.80

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.72

0.70

1.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1011

5962

0.96

0.69

1.4

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1066

5792

1.04

0.64

1.6

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

218

0.78

0.64

1.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.35

0.63

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1088

6374

0.96

0.57

1.5

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

129

1.27

0.54

1.0

1.1

0.02

6.25

u/ml

1.09

103

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.31

0.48

6.0

3.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2081

11517

1.02

0.46

1.5

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.57

0.42

1.2

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

583

0.90

0.42

1.4

1.2

—

(3022670) pH of Venous cord blood

1.41

0.40

1.1

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

1.29

0.39

1.2

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.34

0.39

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.41

0.36

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

393

0.89

0.36

3.0

2.9

124.92

120.61

au/ml

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.41

0.36

1.0

—

(3006598) pH of Arterial cord blood

100

0.79

0.31

1.2

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.32

0.31

1.1

1.0

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

132

1.16

0.25

1.0

1.1

0.04

3.49

u/ml

2.45

100

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.22

0.0

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.22

0.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.23

0.20

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

987

5488

1.02

0.20

1.8

—

(46235168) Fasting glucose [Moles/volume] in Blood

112

0.86

0.19

1.4

1.1

6.80

5.47

mmol/l

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1339

7664

0.99

0.17

1.5

1.4

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.71

0.17

1.2

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.16

0.16

1.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

107

1.11

0.12

2.3

2.7

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.18

0.11

1.1

8.92

8.38

mmol/l

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.12

0.11

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

368

2111

0.99

0.09

1.7

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

0.91

0.08

1.1

1.0

0.10

1.27

u/ml

0.70

(3008607) Semen analysis panel

1.08

0.07

1.2

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

346

0.96

0.07

1.9

2.1

10.02

10.35

mg/l

0.18

287

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.04

0.07

1.2

346.56

298.59

umol/24h

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.92

0.05

1.0

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

527

1.01

0.01

1.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

306

1728

1.00

0.00

3.3

1.7

13.05

13.01

0.34

301

1700

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

312

1766

1.00

0.00

1.6

7.69

7.34

mmol/l

2.28

305

1692

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.01

-0.00

1.2

1.1

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.88

-0.00

5.7

6.2

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.02

-0.00

1.4

1.3

1.46

1.55

mg/l

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: HYPOTHY_PURCHASE – Hypothyroidism and >3 levothyroxin purchases

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Hypothyroidism and >3 levothyroxin purchases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints